JP6679450B2 - Crystal nucleating agent for granular polyolefin resin with improved fluidity - Google Patents
Crystal nucleating agent for granular polyolefin resin with improved fluidity Download PDFInfo
- Publication number
- JP6679450B2 JP6679450B2 JP2016181073A JP2016181073A JP6679450B2 JP 6679450 B2 JP6679450 B2 JP 6679450B2 JP 2016181073 A JP2016181073 A JP 2016181073A JP 2016181073 A JP2016181073 A JP 2016181073A JP 6679450 B2 JP6679450 B2 JP 6679450B2
- Authority
- JP
- Japan
- Prior art keywords
- nucleating agent
- polyolefin resin
- crystal nucleating
- bis
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003484 crystal nucleating agent Substances 0.000 title claims description 194
- 229920005672 polyolefin resin Polymers 0.000 title claims description 167
- -1 diacetal compound Chemical class 0.000 claims description 96
- 125000004432 carbon atom Chemical group C* 0.000 claims description 67
- 238000000034 method Methods 0.000 claims description 65
- 239000000843 powder Substances 0.000 claims description 52
- 238000002844 melting Methods 0.000 claims description 49
- 230000008018 melting Effects 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 36
- 238000003756 stirring Methods 0.000 claims description 36
- 238000002156 mixing Methods 0.000 claims description 33
- 238000004519 manufacturing process Methods 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 26
- 238000010438 heat treatment Methods 0.000 claims description 25
- 238000005469 granulation Methods 0.000 claims description 21
- 230000003179 granulation Effects 0.000 claims description 21
- 239000011342 resin composition Substances 0.000 claims description 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 20
- 239000002667 nucleating agent Substances 0.000 claims description 20
- 238000007906 compression Methods 0.000 claims description 19
- 230000006835 compression Effects 0.000 claims description 19
- ZETHHMPKDUSZQQ-UHFFFAOYSA-N Betulafolienepentol Natural products C1C=C(C)CCC(C(C)CCC=C(C)C)C2C(OC)OC(OC)C2=C1 ZETHHMPKDUSZQQ-UHFFFAOYSA-N 0.000 claims description 18
- HEOKFDGOFROELJ-UHFFFAOYSA-N diacetal Natural products COc1ccc(C=C/c2cc(O)cc(OC3OC(COC(=O)c4cc(O)c(O)c(O)c4)C(O)C(O)C3O)c2)cc1O HEOKFDGOFROELJ-UHFFFAOYSA-N 0.000 claims description 18
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
- 239000000194 fatty acid Substances 0.000 claims description 18
- 229930195729 fatty acid Natural products 0.000 claims description 18
- 150000004665 fatty acids Chemical class 0.000 claims description 18
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 17
- 125000000217 alkyl group Chemical group 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 238000007873 sieving Methods 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- 239000011347 resin Substances 0.000 claims description 13
- 150000007524 organic acids Chemical class 0.000 claims description 12
- 125000005329 tetralinyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 12
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000005843 halogen group Chemical group 0.000 claims description 8
- 239000008187 granular material Substances 0.000 claims description 7
- 229920000098 polyolefin Polymers 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000036760 body temperature Effects 0.000 claims description 4
- 239000013078 crystal Substances 0.000 claims description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims 3
- 230000008025 crystallization Effects 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 150000002989 phenols Chemical class 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 description 60
- 239000000600 sorbitol Substances 0.000 description 32
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 31
- 230000000694 effects Effects 0.000 description 19
- 239000000654 additive Substances 0.000 description 15
- 239000011230 binding agent Substances 0.000 description 15
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 14
- 150000004671 saturated fatty acids Chemical class 0.000 description 14
- 241000519995 Stachys sylvatica Species 0.000 description 12
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 238000000465 moulding Methods 0.000 description 11
- 235000021355 Stearic acid Nutrition 0.000 description 10
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 10
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 10
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 10
- 239000008117 stearic acid Substances 0.000 description 10
- YWEWWNPYDDHZDI-JJKKTNRVSA-N (1r)-1-[(4r,4ar,8as)-2,6-bis(3,4-dimethylphenyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C1=C(C)C(C)=CC=C1C1O[C@H]2[C@@H]([C@H](O)CO)OC(C=3C=C(C)C(C)=CC=3)O[C@H]2CO1 YWEWWNPYDDHZDI-JJKKTNRVSA-N 0.000 description 9
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 9
- PCSMJKASWLYICJ-UHFFFAOYSA-N Succinic aldehyde Chemical class O=CCCC=O PCSMJKASWLYICJ-UHFFFAOYSA-N 0.000 description 9
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 9
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 238000009826 distribution Methods 0.000 description 9
- 229910052751 metal Inorganic materials 0.000 description 9
- 239000002184 metal Substances 0.000 description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 150000002894 organic compounds Chemical class 0.000 description 8
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 8
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 8
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 7
- 239000007983 Tris buffer Substances 0.000 description 7
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 6
- 239000008116 calcium stearate Substances 0.000 description 6
- 235000013539 calcium stearate Nutrition 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 6
- 235000021357 Behenic acid Nutrition 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- BGYHLZZASRKEJE-UHFFFAOYSA-N [3-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]-2,2-bis[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxymethyl]propyl] 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCC(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)(COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)COC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 BGYHLZZASRKEJE-UHFFFAOYSA-N 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 238000013019 agitation Methods 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 229940116226 behenic acid Drugs 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- PAZZVPKITDJCPV-UHFFFAOYSA-N 10-hydroxyoctadecanoic acid Chemical compound CCCCCCCCC(O)CCCCCCCCC(O)=O PAZZVPKITDJCPV-UHFFFAOYSA-N 0.000 description 4
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 4
- RKHXDCVAPIMDMG-UHFFFAOYSA-N 9-hydroxyoctadecanoic acid Chemical compound CCCCCCCCCC(O)CCCCCCCC(O)=O RKHXDCVAPIMDMG-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- JKIJEFPNVSHHEI-UHFFFAOYSA-N Phenol, 2,4-bis(1,1-dimethylethyl)-, phosphite (3:1) Chemical compound CC(C)(C)C1=CC(C(C)(C)C)=CC=C1OP(OC=1C(=CC(=CC=1)C(C)(C)C)C(C)(C)C)OC1=CC=C(C(C)(C)C)C=C1C(C)(C)C JKIJEFPNVSHHEI-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 4
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 4
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 4
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 4
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Chemical class C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Chemical class O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- IAQRGUVFOMOMEM-UHFFFAOYSA-N butene Natural products CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 239000002270 dispersing agent Substances 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 3
- ZFSLODLOARCGLH-UHFFFAOYSA-N isocyanuric acid Chemical compound OC1=NC(O)=NC(O)=N1 ZFSLODLOARCGLH-UHFFFAOYSA-N 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229960004274 stearic acid Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Chemical class OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- FMZUHGYZWYNSOA-VVBFYGJXSA-N (1r)-1-[(4r,4ar,8as)-2,6-diphenyl-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound C([C@@H]1OC(O[C@@H]([C@@H]1O1)[C@H](O)CO)C=2C=CC=CC=2)OC1C1=CC=CC=C1 FMZUHGYZWYNSOA-VVBFYGJXSA-N 0.000 description 2
- CCLARULDIPFTCP-BOYHRMMASA-N (2r,3r,4r,5s)-heptane-1,2,3,4,5,6-hexol Chemical compound CC(O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CCLARULDIPFTCP-BOYHRMMASA-N 0.000 description 2
- VNQNXQYZMPJLQX-UHFFFAOYSA-N 1,3,5-tris[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-1,3,5-triazinane-2,4,6-trione Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CN2C(N(CC=3C=C(C(O)=C(C=3)C(C)(C)C)C(C)(C)C)C(=O)N(CC=3C=C(C(O)=C(C=3)C(C)(C)C)C(C)(C)C)C2=O)=O)=C1 VNQNXQYZMPJLQX-UHFFFAOYSA-N 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- DCTOHCCUXLBQMS-UHFFFAOYSA-N 1-undecene Chemical compound CCCCCCCCCC=C DCTOHCCUXLBQMS-UHFFFAOYSA-N 0.000 description 2
- ROHFBIREHKPELA-UHFFFAOYSA-N 2-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]prop-2-enoic acid;methane Chemical compound C.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O.CC(C)(C)C1=CC(CC(=C)C(O)=O)=CC(C(C)(C)C)=C1O ROHFBIREHKPELA-UHFFFAOYSA-N 0.000 description 2
- JMMZCWZIJXAGKW-UHFFFAOYSA-N 2-methylpent-2-ene Chemical compound CCC=C(C)C JMMZCWZIJXAGKW-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- MDWVSAYEQPLWMX-UHFFFAOYSA-N 4,4'-Methylenebis(2,6-di-tert-butylphenol) Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 MDWVSAYEQPLWMX-UHFFFAOYSA-N 0.000 description 2
- PRWJPWSKLXYEPD-UHFFFAOYSA-N 4-[4,4-bis(5-tert-butyl-4-hydroxy-2-methylphenyl)butan-2-yl]-2-tert-butyl-5-methylphenol Chemical compound C=1C(C(C)(C)C)=C(O)C=C(C)C=1C(C)CC(C=1C(=CC(O)=C(C=1)C(C)(C)C)C)C1=CC(C(C)(C)C)=C(O)C=C1C PRWJPWSKLXYEPD-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- OKOBUGCCXMIKDM-UHFFFAOYSA-N Irganox 1098 Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)NCCCCCCNC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 OKOBUGCCXMIKDM-UHFFFAOYSA-N 0.000 description 2
- 235000021353 Lignoceric acid Nutrition 0.000 description 2
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 2
- MOABYHZDQQELLG-UHFFFAOYSA-N OP(O)OP(O)O.C(CCCCCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCCCCC Chemical compound OP(O)OP(O)O.C(CCCCCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCCCCC MOABYHZDQQELLG-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005062 Polybutadiene Substances 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005529 alkyleneoxy group Chemical group 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical class C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 2
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 239000002530 phenolic antioxidant Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920002857 polybutadiene Polymers 0.000 description 2
- 229920005673 polypropylene based resin Polymers 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 238000010079 rubber tapping Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- GWHCXVQVJPWHRF-KTKRTIGZSA-N (15Z)-tetracosenoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-KTKRTIGZSA-N 0.000 description 1
- FGHOOJSIEHYJFQ-UHFFFAOYSA-N (2,4-ditert-butylphenyl) dihydrogen phosphite Chemical compound CC(C)(C)C1=CC=C(OP(O)O)C(C(C)(C)C)=C1 FGHOOJSIEHYJFQ-UHFFFAOYSA-N 0.000 description 1
- HZVFRKSYUGFFEJ-YVECIDJPSA-N (2r,3r,4s,5r)-7-phenylhept-6-ene-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=CC1=CC=CC=C1 HZVFRKSYUGFFEJ-YVECIDJPSA-N 0.000 description 1
- CHEANNSDVJOIBS-MHZLTWQESA-N (3s)-3-cyclopropyl-3-[3-[[3-(5,5-dimethylcyclopenten-1-yl)-4-(2-fluoro-5-methoxyphenyl)phenyl]methoxy]phenyl]propanoic acid Chemical compound COC1=CC=C(F)C(C=2C(=CC(COC=3C=C(C=CC=3)[C@@H](CC(O)=O)C3CC3)=CC=2)C=2C(CCC=2)(C)C)=C1 CHEANNSDVJOIBS-MHZLTWQESA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 1
- FGYKUFVNYVMTAM-UHFFFAOYSA-N (R)-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3t,7t,11-trienyl)-chroman-6-ol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-UHFFFAOYSA-N 0.000 description 1
- HVGRZDASOHMCSK-UHFFFAOYSA-N (Z,Z)-13,16-docosadienoic acid Natural products CCCCCC=CCC=CCCCCCCCCCCCC(O)=O HVGRZDASOHMCSK-UHFFFAOYSA-N 0.000 description 1
- CRSBERNSMYQZNG-UHFFFAOYSA-N 1 -dodecene Natural products CCCCCCCCCCC=C CRSBERNSMYQZNG-UHFFFAOYSA-N 0.000 description 1
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- XZZWOTQMUOIIFX-UHFFFAOYSA-N 1-(2-diphenoxyphosphanyloxypropoxy)propan-2-yl diphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC(C)COCC(C)OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 XZZWOTQMUOIIFX-UHFFFAOYSA-N 0.000 description 1
- PIYNPBVOTLQBTC-UHFFFAOYSA-N 1-[8-propyl-2,6-bis(4-propylphenyl)-4,4a,8,8a-tetrahydro-[1,3]dioxino[5,4-d][1,3]dioxin-4-yl]ethane-1,2-diol Chemical compound O1C2C(CCC)OC(C=3C=CC(CCC)=CC=3)OC2C(C(O)CO)OC1C1=CC=C(CCC)C=C1 PIYNPBVOTLQBTC-UHFFFAOYSA-N 0.000 description 1
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 1
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 description 1
- DXCHWXWXYPEZKM-UHFFFAOYSA-N 2,4-ditert-butyl-6-[1-(3,5-ditert-butyl-2-hydroxyphenyl)ethyl]phenol Chemical compound C=1C(C(C)(C)C)=CC(C(C)(C)C)=C(O)C=1C(C)C1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1O DXCHWXWXYPEZKM-UHFFFAOYSA-N 0.000 description 1
- LKALLEFLBKHPTQ-UHFFFAOYSA-N 2,6-bis[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenol Chemical compound OC=1C(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=CC(C)=CC=1CC1=CC(C)=CC(C(C)(C)C)=C1O LKALLEFLBKHPTQ-UHFFFAOYSA-N 0.000 description 1
- DKCPKDPYUFEZCP-UHFFFAOYSA-N 2,6-di-tert-butylphenol Chemical compound CC(C)(C)C1=CC=CC(C(C)(C)C)=C1O DKCPKDPYUFEZCP-UHFFFAOYSA-N 0.000 description 1
- XQESJWNDTICJHW-UHFFFAOYSA-N 2-[(2-hydroxy-5-methyl-3-nonylphenyl)methyl]-4-methyl-6-nonylphenol Chemical compound CCCCCCCCCC1=CC(C)=CC(CC=2C(=C(CCCCCCCCC)C=C(C)C=2)O)=C1O XQESJWNDTICJHW-UHFFFAOYSA-N 0.000 description 1
- YIKVZDICBNEEOZ-UHFFFAOYSA-N 2-ethylhexyl dihydrogen phosphite Chemical compound CCCCC(CC)COP(O)O YIKVZDICBNEEOZ-UHFFFAOYSA-N 0.000 description 1
- TVWGHFVGFWIHFN-UHFFFAOYSA-N 2-hexadecan-2-yl-4,6-dimethylphenol Chemical compound CCCCCCCCCCCCCCC(C)C1=CC(C)=CC(C)=C1O TVWGHFVGFWIHFN-UHFFFAOYSA-N 0.000 description 1
- HXIQYSLFEXIOAV-UHFFFAOYSA-N 2-tert-butyl-4-(5-tert-butyl-4-hydroxy-2-methylphenyl)sulfanyl-5-methylphenol Chemical compound CC1=CC(O)=C(C(C)(C)C)C=C1SC1=CC(C(C)(C)C)=C(O)C=C1C HXIQYSLFEXIOAV-UHFFFAOYSA-N 0.000 description 1
- PFANXOISJYKQRP-UHFFFAOYSA-N 2-tert-butyl-4-[1-(5-tert-butyl-4-hydroxy-2-methylphenyl)butyl]-5-methylphenol Chemical compound C=1C(C(C)(C)C)=C(O)C=C(C)C=1C(CCC)C1=CC(C(C)(C)C)=C(O)C=C1C PFANXOISJYKQRP-UHFFFAOYSA-N 0.000 description 1
- GPNYZBKIGXGYNU-UHFFFAOYSA-N 2-tert-butyl-6-[(3-tert-butyl-5-ethyl-2-hydroxyphenyl)methyl]-4-ethylphenol Chemical compound CC(C)(C)C1=CC(CC)=CC(CC=2C(=C(C=C(CC)C=2)C(C)(C)C)O)=C1O GPNYZBKIGXGYNU-UHFFFAOYSA-N 0.000 description 1
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 1
- PZRWFKGUFWPFID-UHFFFAOYSA-N 3,9-dioctadecoxy-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane Chemical compound C1OP(OCCCCCCCCCCCCCCCCCC)OCC21COP(OCCCCCCCCCCCCCCCCCC)OC2 PZRWFKGUFWPFID-UHFFFAOYSA-N 0.000 description 1
- YHMYLDCYUHBSNP-UHFFFAOYSA-N 4-butan-2-yl-2-tert-butylphenol Chemical compound CCC(C)C1=CC=C(O)C(C(C)(C)C)=C1 YHMYLDCYUHBSNP-UHFFFAOYSA-N 0.000 description 1
- OILMLWAZYNVPMG-UHFFFAOYSA-N 4-methyl-2-nonylphenol Chemical compound CCCCCCCCCC1=CC(C)=CC=C1O OILMLWAZYNVPMG-UHFFFAOYSA-N 0.000 description 1
- JJHKARPEMHIIQC-UHFFFAOYSA-N 4-octadecoxy-2,6-diphenylphenol Chemical compound C=1C(OCCCCCCCCCCCCCCCCCC)=CC(C=2C=CC=CC=2)=C(O)C=1C1=CC=CC=C1 JJHKARPEMHIIQC-UHFFFAOYSA-N 0.000 description 1
- MXJGWNPVKBVVTM-UHFFFAOYSA-N 5-tert-butyl-1,3-benzoxazole Chemical compound CC(C)(C)C1=CC=C2OC=NC2=C1 MXJGWNPVKBVVTM-UHFFFAOYSA-N 0.000 description 1
- ZVVFVKJZNVSANF-UHFFFAOYSA-N 6-[3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoyloxy]hexyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CCC(=O)OCCCCCCOC(=O)CCC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)=C1 ZVVFVKJZNVSANF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ADRNSOYXKABLGT-UHFFFAOYSA-N 8-methylnonyl diphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OCCCCCCCC(C)C)OC1=CC=CC=C1 ADRNSOYXKABLGT-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- FBYQNWXFWALIKJ-UHFFFAOYSA-N C1(=CC=CC=C1)C(CCCCCCCCCP(O)(O)O)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)C(CCCCCCCCCP(O)(O)O)C1=CC=CC=C1 FBYQNWXFWALIKJ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102100026816 DNA-dependent metalloprotease SPRTN Human genes 0.000 description 1
- 101710175461 DNA-dependent metalloprotease SPRTN Proteins 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical compound CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 239000004593 Epoxy Chemical class 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- HBBGRARXTFLTSG-UHFFFAOYSA-N Lithium ion Chemical compound [Li+] HBBGRARXTFLTSG-UHFFFAOYSA-N 0.000 description 1
- 239000004594 Masterbatch (MB) Substances 0.000 description 1
- XJXROGWVRIJYMO-SJDLZYGOSA-N Nervonic acid Natural products O=C(O)[C@@H](/C=C/CCCCCCCC)CCCCCCCCCCCC XJXROGWVRIJYMO-SJDLZYGOSA-N 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- QAEPIAHUOVJOOM-UHFFFAOYSA-N OP(O)OP(O)O.C(CCCCCCCC)C1=C(C=CC=C1)C(O)(C(CO)(CO)CO)C1=C(C=CC=C1)CCCCCCCCC Chemical compound OP(O)OP(O)O.C(CCCCCCCC)C1=C(C=CC=C1)C(O)(C(CO)(CO)CO)C1=C(C=CC=C1)CCCCCCCCC QAEPIAHUOVJOOM-UHFFFAOYSA-N 0.000 description 1
- BENNPBRBSFRLGP-UHFFFAOYSA-N OP(O)OP(O)O.C(CCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCC Chemical compound OP(O)OP(O)O.C(CCCCCCCCC)C(O)(C(CO)(CO)CO)CCCCCCCCCC BENNPBRBSFRLGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- LZNWGSIDNAGRAJ-UHFFFAOYSA-N P(O)(O)OC(C(C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)(C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)(CCCCCCCCCCCCC)C1=CC=CC=C1 Chemical compound P(O)(O)OC(C(C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)(C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)C(OP(O)O)(CCCCCCCCCCCCC)C1=CC=CC=C1)(CCCCCCCCCCCCC)C1=CC=CC=C1 LZNWGSIDNAGRAJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- CGRTZESQZZGAAU-UHFFFAOYSA-N [2-[3-[1-[3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoyloxy]-2-methylpropan-2-yl]-2,4,8,10-tetraoxaspiro[5.5]undecan-9-yl]-2-methylpropyl] 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propanoate Chemical compound CC(C)(C)C1=C(O)C(C)=CC(CCC(=O)OCC(C)(C)C2OCC3(CO2)COC(OC3)C(C)(C)COC(=O)CCC=2C=C(C(O)=C(C)C=2)C(C)(C)C)=C1 CGRTZESQZZGAAU-UHFFFAOYSA-N 0.000 description 1
- IORUEKDKNHHQAL-UHFFFAOYSA-N [2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenyl] prop-2-enoate Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)OC(=O)C=C)=C1O IORUEKDKNHHQAL-UHFFFAOYSA-N 0.000 description 1
- VMNKHSPZIGIPLL-UHFFFAOYSA-N [3-hydroxy-2,2-bis(hydroxymethyl)propyl] dihydrogen phosphite Chemical compound OCC(CO)(CO)COP(O)O VMNKHSPZIGIPLL-UHFFFAOYSA-N 0.000 description 1
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- ZGNIGAHODXRWIT-UHFFFAOYSA-K aluminum;4-tert-butylbenzoate Chemical class [Al+3].CC(C)(C)C1=CC=C(C([O-])=O)C=C1.CC(C)(C)C1=CC=C(C([O-])=O)C=C1.CC(C)(C)C1=CC=C(C([O-])=O)C=C1 ZGNIGAHODXRWIT-UHFFFAOYSA-K 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 150000004982 aromatic amines Chemical group 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical class [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- XDFCIPNJCBUZJN-UHFFFAOYSA-N barium(2+) Chemical compound [Ba+2] XDFCIPNJCBUZJN-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- FGYKUFVNYVMTAM-YMCDKREISA-N beta-Tocotrienol Natural products Oc1c(C)c2c(c(C)c1)O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CC2 FGYKUFVNYVMTAM-YMCDKREISA-N 0.000 description 1
- KYQRDNYMKKJUTH-UHFFFAOYSA-N bicyclo[2.2.1]heptane-3,4-dicarboxylic acid Chemical compound C1CC2(C(O)=O)C(C(=O)O)CC1C2 KYQRDNYMKKJUTH-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- OCWYEMOEOGEQAN-UHFFFAOYSA-N bumetrizole Chemical compound CC(C)(C)C1=CC(C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O OCWYEMOEOGEQAN-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical group [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- RXPKHKBYUIHIGL-UHFFFAOYSA-L calcium;12-hydroxyoctadecanoate Chemical compound [Ca+2].CCCCCCC(O)CCCCCCCCCCC([O-])=O.CCCCCCC(O)CCCCCCCCCCC([O-])=O RXPKHKBYUIHIGL-UHFFFAOYSA-L 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001734 carboxylic acid salts Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229920006038 crystalline resin Polymers 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- QYQADNCHXSEGJT-UHFFFAOYSA-N cyclohexane-1,1-dicarboxylate;hydron Chemical compound OC(=O)C1(C(O)=O)CCCCC1 QYQADNCHXSEGJT-UHFFFAOYSA-N 0.000 description 1
- QSAWQNUELGIYBC-UHFFFAOYSA-N cyclohexane-1,2-dicarboxylic acid Chemical compound OC(=O)C1CCCCC1C(O)=O QSAWQNUELGIYBC-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- SHFGJEQAOUMGJM-UHFFFAOYSA-N dialuminum dipotassium disodium dioxosilane iron(3+) oxocalcium oxomagnesium oxygen(2-) Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Na+].[Na+].[Al+3].[Al+3].[K+].[K+].[Fe+3].[Fe+3].O=[Mg].O=[Ca].O=[Si]=O SHFGJEQAOUMGJM-UHFFFAOYSA-N 0.000 description 1
- CRHLEZORXKQUEI-UHFFFAOYSA-N dialuminum;cobalt(2+);oxygen(2-) Chemical class [O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Co+2].[Co+2] CRHLEZORXKQUEI-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical group OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- YNLAOSYQHBDIKW-UHFFFAOYSA-M diethylaluminium chloride Chemical compound CC[Al](Cl)CC YNLAOSYQHBDIKW-UHFFFAOYSA-M 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- CVCXSNONTRFSEH-UHFFFAOYSA-N docosa-2,4-dienoic acid Chemical compound CCCCCCCCCCCCCCCCCC=CC=CC(O)=O CVCXSNONTRFSEH-UHFFFAOYSA-N 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 229940069096 dodecene Drugs 0.000 description 1
- 239000000555 dodecyl gallate Substances 0.000 description 1
- 235000010386 dodecyl gallate Nutrition 0.000 description 1
- 229940080643 dodecyl gallate Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- FGYKUFVNYVMTAM-MUUNZHRXSA-N epsilon-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-MUUNZHRXSA-N 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 1
- OTXNTMVVOOBZCV-YMCDKREISA-N gamma-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CCc2c1 OTXNTMVVOOBZCV-YMCDKREISA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- TYCUSKFOGZNIBO-UHFFFAOYSA-N hexadecyl 3,4,5-trihydroxybenzoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 TYCUSKFOGZNIBO-UHFFFAOYSA-N 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229910001416 lithium ion Inorganic materials 0.000 description 1
- VIALJPAGUCTUBQ-UHFFFAOYSA-L magnesium;12-hydroxyoctadecanoate Chemical compound [Mg+2].CCCCCCC(O)CCCCCCCCCCC([O-])=O.CCCCCCC(O)CCCCCCCCCCC([O-])=O VIALJPAGUCTUBQ-UHFFFAOYSA-L 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920001179 medium density polyethylene Polymers 0.000 description 1
- 239000004701 medium-density polyethylene Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 239000012968 metallocene catalyst Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N n-decene Natural products CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- BRNPAEUKZMBRLQ-UHFFFAOYSA-N octadecyl 3,4,5-trihydroxybenzoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 BRNPAEUKZMBRLQ-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 239000010451 perlite Substances 0.000 description 1
- 235000019362 perlite Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008301 phosphite esters Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical class N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920005678 polyethylene based resin Polymers 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920005630 polypropylene random copolymer Polymers 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229920001384 propylene homopolymer Polymers 0.000 description 1
- 229920005604 random copolymer Polymers 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000001175 rotational moulding Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229920002545 silicone oil Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- KKEYFWRCBNTPAC-UHFFFAOYSA-L terephthalate(2-) Chemical compound [O-]C(=O)C1=CC=C(C([O-])=O)C=C1 KKEYFWRCBNTPAC-UHFFFAOYSA-L 0.000 description 1
- ISIJQEHRDSCQIU-UHFFFAOYSA-N tert-butyl 2,7-diazaspiro[4.5]decane-7-carboxylate Chemical compound C1N(C(=O)OC(C)(C)C)CCCC11CNCC1 ISIJQEHRDSCQIU-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- YONPGGFAJWQGJC-UHFFFAOYSA-K titanium(iii) chloride Chemical compound Cl[Ti](Cl)Cl YONPGGFAJWQGJC-UHFFFAOYSA-K 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 150000003623 transition metal compounds Chemical class 0.000 description 1
- BWPNIANVWARHPR-UHFFFAOYSA-N tridecyl dihydrogen phosphite Chemical compound CCCCCCCCCCCCCOP(O)O BWPNIANVWARHPR-UHFFFAOYSA-N 0.000 description 1
- IVIIAEVMQHEPAY-UHFFFAOYSA-N tridodecyl phosphite Chemical compound CCCCCCCCCCCCOP(OCCCCCCCCCCCC)OCCCCCCCCCCCC IVIIAEVMQHEPAY-UHFFFAOYSA-N 0.000 description 1
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 1
- VOITXYVAKOUIBA-UHFFFAOYSA-N triethylaluminium Chemical compound CC[Al](CC)CC VOITXYVAKOUIBA-UHFFFAOYSA-N 0.000 description 1
- CNUJLMSKURPSHE-UHFFFAOYSA-N trioctadecyl phosphite Chemical compound CCCCCCCCCCCCCCCCCCOP(OCCCCCCCCCCCCCCCCCC)OCCCCCCCCCCCCCCCCCC CNUJLMSKURPSHE-UHFFFAOYSA-N 0.000 description 1
- ILLOBGFGKYTZRO-UHFFFAOYSA-N tris(2-ethylhexyl) phosphite Chemical compound CCCCC(CC)COP(OCC(CC)CCCC)OCC(CC)CCCC ILLOBGFGKYTZRO-UHFFFAOYSA-N 0.000 description 1
- JZNDMMGBXUYFNQ-UHFFFAOYSA-N tris(dodecylsulfanyl)phosphane Chemical compound CCCCCCCCCCCCSP(SCCCCCCCCCCCC)SCCCCCCCCCCCC JZNDMMGBXUYFNQ-UHFFFAOYSA-N 0.000 description 1
- QQBLOZGVRHAYGT-UHFFFAOYSA-N tris-decyl phosphite Chemical compound CCCCCCCCCCOP(OCCCCCCCCCC)OCCCCCCCCCC QQBLOZGVRHAYGT-UHFFFAOYSA-N 0.000 description 1
- PEXOFOFLXOCMDX-UHFFFAOYSA-N tritridecyl phosphite Chemical compound CCCCCCCCCCCCCOP(OCCCCCCCCCCCCC)OCCCCCCCCCCCCC PEXOFOFLXOCMDX-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- FRZSCIVUSFMNBX-UHFFFAOYSA-L zinc;12-hydroxyoctadecanoate Chemical compound [Zn+2].CCCCCCC(O)CCCCCCCCCCC([O-])=O.CCCCCCC(O)CCCCCCCCCCC([O-])=O FRZSCIVUSFMNBX-UHFFFAOYSA-L 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011723 β-tocotrienol Substances 0.000 description 1
- 235000019151 β-tocotrienol Nutrition 0.000 description 1
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
- 239000011722 γ-tocotrienol Substances 0.000 description 1
- 235000019150 γ-tocotrienol Nutrition 0.000 description 1
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
Description
本発明は、ポリオレフィン系樹脂用結晶核剤の流動性の改良に関するものであり、詳しくは、顆粒化による流動性の改良方法、その方法を含む流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤の製造方法及び該方法により得られた流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤、更にその結晶核剤を含んでなる透明性に優れたポリオレフィン系樹脂組成物及びその成形体に関する。 The present invention relates to improvement of the fluidity of a crystal nucleating agent for a polyolefin resin, and more specifically, a method of improving fluidity by granulation, and a crystal for a granular polyolefin resin having improved fluidity including the method. Method for producing nucleating agent, crystal nucleating agent for granular polyolefin resin having improved fluidity obtained by the method, polyolefin resin composition having excellent transparency comprising the crystal nucleating agent, and molding thereof Regarding the body
ポリエチレンやポリプロピレン等のポリオレフィン系樹脂は、安価でバランスの良い性能を有し、汎用のプラスチックとして様々な用途で使用されている。また、一般にポリオレフィン系樹脂は結晶性の樹脂であり、生産効率の向上を目的に、また機械的特性や熱的特性、光学的特性を向上する目的で結晶核剤を加えて用いられることが多い。特に、光学的特性である透明性の改善には結晶核剤の配合が不可欠である。 Polyolefin resins such as polyethylene and polypropylene are inexpensive and have well-balanced performance, and are used in various applications as general-purpose plastics. In general, polyolefin resins are crystalline resins and are often added with a crystal nucleating agent for the purpose of improving production efficiency, mechanical properties, thermal properties, and optical properties. . In particular, in order to improve the optical property of transparency, it is indispensable to add a crystal nucleating agent.
前記結晶核剤には、タルク等の無機系の結晶核剤とジアセタール化合物、カルボン酸やリン酸エステルの金属塩等の有機系の結晶核剤があり、更に有機系の結晶核剤には溶解タイプと非溶解タイプの結晶核剤がある。透明性等の光学的特性の改善には前記ジアセタール系化合物に代表される溶解タイプの有機系の結晶核剤が特に有効であり、多く用いられている。 The crystal nucleating agent includes an inorganic crystal nucleating agent such as talc and an organic crystal nucleating agent such as a diacetal compound, a metal salt of a carboxylic acid or a phosphoric acid ester, and further dissolved in an organic crystal nucleating agent. There are two types of crystal nucleating agents: non-dissolving type and crystal type. Soluble organic crystal nucleating agents represented by the diacetal compounds are particularly effective and widely used for improving optical properties such as transparency.
汎用プラスチック、特にポリオレフィン系樹脂の特徴の一つは、安価であることであり、その為には生産性に優れることが重要であり、上述の様に結晶核剤を加えることによる成形サイクルの短縮等の様々な工夫がなされている。原料のフィード性もその一つであり、個々の原料のフィード性、即ちその流動性に優れることが必要である。しかし、上記結晶核剤、なかでもジアセタール系の結晶核剤は流動性が悪く、生産性における大きな問題であった。 One of the characteristics of general-purpose plastics, especially polyolefin-based resins, is that they are inexpensive, and for that reason it is important to have excellent productivity. As described above, the addition of a crystal nucleating agent shortens the molding cycle. Etc. are variously devised. The feedability of the raw materials is one of them, and it is necessary that the feedability of each raw material, that is, its fluidity is excellent. However, the above crystal nucleating agents, especially diacetal type crystal nucleating agents, have poor fluidity, which has been a serious problem in productivity.
そのため、これまでにもジアセタール系化合物をはじめとした結晶核剤の流動性の改良に関して様々な検討がなされてきた。例えば、粒状化することにより流動性を改良する方法(特許文献1〜3)や、粒状化せず、流動性改良剤を加えることにより流動性を改良する方法(特許文献4〜7)などが提案されており、実際に使われている。 Therefore, various studies have been made so far regarding the improvement of the fluidity of crystal nucleating agents including diacetal compounds. For example, a method of improving fluidity by granulating (Patent Documents 1 to 3), a method of improving fluidity by adding a fluidity improver without granulating (Patent Documents 4 to 7), and the like. Proposed and in use.
近年、汎用プラスチックにおいては、より一層の生産性の向上が求められており、原料のフィード性、即ちその流動性のより一層の改善が求められており、上記結晶核剤、なかでもジアセタール系の結晶核剤の流動性の更なる改善が生産性を向上する上での大きな課題であった。 In recent years, in general-purpose plastics, further improvement in productivity is required, and feedability of raw materials, that is, further improvement in fluidity thereof, is required, and the above crystal nucleating agent, especially diacetal type Further improvement in the fluidity of the crystal nucleating agent has been a major issue in improving productivity.
上記の通り、流動性の改良方法としては、結晶核剤に限らず一般的に次の2つの方法が知られており、広く使われている。
(1)粒径等の粒子形状をコントロールする方法
(2)流動性の改良に有効な添加剤、即ち流動性改良剤を添加する方法
As described above, the following two methods are generally known and widely used as the method of improving fluidity, not limited to the crystal nucleating agent.
(1) Method of controlling particle shape such as particle diameter (2) Method of adding additive effective for improving fluidity, that is, fluidity improver
上述の様に、近年流動性に対する要求は益々厳しくなるなかで、(2)の方法では、その要求を十分に満たすことが難しいのが現状であった。従って、より厳しい流動性が求められる用途では(1)の方法が使われることが多い。 As mentioned above, in recent years, the demand for liquidity has become more and more stringent, and it has been difficult for the method (2) to sufficiently meet the demand. Therefore, the method (1) is often used in applications where more severe fluidity is required.
(1)の方法の場合、一般に、粒径が大きいほど流動性が良くなる傾向にあり、核剤単独または他の添加剤と混合して粒状化する方法や予め樹脂と混合してマスターバッチ化する方法などが汎用的な方法として使われている。 In the case of the method (1), in general, the larger the particle size, the better the fluidity, and the method of granulating the nucleating agent alone or by mixing with other additives, or by mixing with the resin in advance to form a masterbatch. The method to do is used as a general-purpose method.
しかし、粒状化した場合、流動性は改良されるが、ポリオレフィン系樹脂中での分散性や溶解性が悪くなる傾向があり、その結果、核剤本来の透明性等の性能の低下だけでなく、白点等の外観上の問題も生じる懸念があり、特に分散性等に対する要求が厳しい分野では、バインダー等の添加剤を加える方法が一般的であり、その選択が重要である。 However, when granulated, the fluidity is improved, but the dispersibility and solubility in the polyolefin-based resin tend to deteriorate, and as a result, not only the performance such as the transparency inherent to the nucleating agent is deteriorated but also However, there is a concern that appearance problems such as white spots may occur, and particularly in a field where demands for dispersibility and the like are severe, a method of adding an additive such as a binder is common, and selection thereof is important.
上記バインダーとしては、これまでにも様々な化合物が検討されてきたが、帯電防止剤や滑剤としてポリオレフィン用添加剤に広く用いられている有機酸モノグリセリドが、使い勝手の良いバインダーとして知られている。 As the binder, various compounds have been studied so far, but organic acid monoglycerides, which are widely used as additives for polyolefins as antistatic agents and lubricants, are known as easy-to-use binders.
また、粒状化する方法も流動性に対して重要であり、その方法に関しても、これまでに様々な検討がなされており、現状では押出造粒法や圧縮造粒法などが汎用的であり、広く使われている。 Further, the method of granulating is also important for fluidity, and various studies have been made so far regarding that method as well, and at present, the extrusion granulation method and the compression granulation method are general, Widely used.
一方、最近の傾向として、全般的に環境問題等を配慮して、また配合処方の融通性を確保するため、結晶核剤以外の成分の量をできるだけ少なくする方向に進んでおり、できるだけ少ない量のバインダーで粒状化する方法が望まれている。また、用途によっては、バインダーの配合による核剤そのものの性能への影響も懸念されるケースがあり、バインダー量の低減はその観点からも待ち望まれていた。しかし、上記押出造粒法や圧縮造粒法では、ある量以上のバインダーを含まないと粒状化が難しく、バインダー量の低減には限界があった。 On the other hand, as a recent trend, in consideration of environmental issues etc. in general, and in order to ensure the flexibility of the compounding formulation, the amount of components other than the crystal nucleating agent is being reduced as much as possible. There is a demand for a method of granulating with the above binder. In addition, depending on the application, there are cases in which the performance of the nucleating agent itself may be affected by the blending of the binder, and the reduction of the binder amount has been desired from that viewpoint. However, in the above extrusion granulation method and compression granulation method, granulation is difficult unless the binder is contained in a certain amount or more, and there is a limit to the reduction of the binder amount.
さらに、用途によっては、上述の樹脂中での分散性や溶解性に関してもより要求が厳しくなっており、有機酸モノグリセリド等の比較的融点の低いバインダーを大量に加える必要があった。しかし、その場合、バインダーに起因するケーキング等の新たな問題の発生が指摘されており、その改善が必要となっていた。 Further, depending on the use, the demands on the dispersibility and solubility in the above-mentioned resin are more severe, and it is necessary to add a large amount of a binder having a relatively low melting point such as organic acid monoglyceride. However, in that case, it has been pointed out that a new problem such as caking due to the binder has occurred, and improvement thereof has been required.
特に、ジアセタール系化合物等の結晶核剤の場合、二次凝集性等の問題があり、更に、溶融樹脂中での分散性や溶解性がその核剤性能に大きく影響することが知られており、従来公知の系での粒状化では、全ての要求を十分に満足することが難しいのが現状であり、その改善が強く望まれている。 In particular, in the case of a crystal nucleating agent such as a diacetal compound, there are problems such as secondary cohesiveness, and it is known that dispersibility and solubility in a molten resin greatly affect the performance of the nucleating agent. At present, it is difficult to sufficiently satisfy all the requirements by granulation using a conventionally known system, and improvement thereof is strongly desired.
本発明は、顆粒化によるポリオレフィン系樹脂用結晶核剤の流動性を改良する方法、その方法を含む流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤の製造方法及び該方法により得られた流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤、更にその結晶核剤を含んでなる透明性に優れたポリオレフィン系樹脂組成物及びその成形体を提供することを目的とする。 The present invention provides a method for improving the fluidity of a crystal nucleating agent for a polyolefin resin by granulation, a method for producing a crystal nucleating agent for a granular polyolefin resin having improved fluidity including the method, and a method for obtaining the same. Another object of the present invention is to provide a crystal nucleating agent for a granular polyolefin resin having improved fluidity, a polyolefin resin composition excellent in transparency and containing the crystal nucleating agent, and a molded article thereof.
本発明者らは、上述の状況に鑑み、上記課題を解決すべく、鋭意検討した結果、バインダー効果を有する特定の化合物を特定の比率で配合し、更に特定の条件下で攪拌混合することにより、少ない特定の化合物の使用量で顆粒状ポリオレフィン系樹脂用結晶核剤を製造することが可能であり、得られた顆粒状ポリオレフィン系樹脂用結晶核剤は、ケーキング等の問題もなく、樹脂中での分散性や溶解性に優れ、且つ著しく改良された流動性を示し、更にその結晶核剤を含んでなるポリオレフィン系樹脂組成物及びその成形体が透明性にも非常に優れていることを見出し、本発明を完成するに至った。 In view of the above situation, the present inventors have made intensive studies to solve the above problems, and as a result, blend a specific compound having a binder effect in a specific ratio, and further stir and mix under specific conditions. It is possible to produce a crystal nucleating agent for granular polyolefin-based resins with a small amount of a specific compound used, and the obtained crystal nucleating agent for granular polyolefin-based resins has no problems such as caking and It has excellent dispersibility and solubility in, and shows significantly improved fluidity, and that the polyolefin resin composition and its molded product containing the crystal nucleating agent are also very excellent in transparency. Heading out, the present invention has been completed.
即ち、本発明は以下に示すポリオレフィン系樹脂用結晶核剤の流動性改良方法、その方法を含む流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤の製造方法及び該方法により得られた流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤、更にその結晶核剤を含んでなる透明性に優れたポリオレフィン系樹脂組成物及びその成形体を提供するものである。 That is, the present invention was obtained by the following method for improving the fluidity of a crystal nucleating agent for a polyolefin resin, a method for producing a granular nucleating agent for a polyolefin resin having improved fluidity including the method, and the method. The present invention provides a crystal nucleating agent for a granular polyolefin resin having improved fluidity, a polyolefin resin composition excellent in transparency and containing the crystal nucleating agent, and a molded product thereof.
[項1] ポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド、(C)100℃以上の融点を有する有機化合物を含んでなる顆粒状ポリオレフィン系樹脂用結晶核剤であり、
該顆粒状ポリオレフィン系樹脂用結晶核剤中に占める(A)成分の割合が60〜80重量%であり、(B)成分の割合が10〜30重量%であり、(B)成分と(C)成分の合計の割合が20〜40重量%であり、更に、
(B)成分と(C)成分の合計量中に占める(B)成分の割合が30〜80重量%であり、且つ、該顆粒状ポリオレフィン系樹脂用結晶核剤が、粉体温度を(B)成分の融点以上、(C)成分の融点以下の温度範囲に制御しながら、加熱混合されたものであることを特徴とする顆粒状ポリオレフィン系樹脂用結晶核剤。
[Item 1] A crystal nucleating agent for a polyolefin resin, comprising (B) an organic acid monoglyceride, and (C) an organic compound having a melting point of 100 ° C. or higher.
The proportion of the component (A) in the crystal nucleating agent for a granular polyolefin resin is 60 to 80% by weight, the proportion of the component (B) is 10 to 30% by weight, and the components (B) and (C ) The total proportion of the components is 20 to 40% by weight, and
The proportion of the component (B) in the total amount of the component (B) and the component (C) is 30 to 80% by weight, and the crystal nucleating agent for the granular polyolefin resin has a powder temperature of (B A crystalline nucleating agent for a granular polyolefin resin, which is heated and mixed while being controlled in a temperature range from the melting point of the component) to the melting point of the component (C).
[項2] 前記(A)成分の割合が65〜75重量%、(B)成分の割合が13〜25重量%、(B)成分と(C)成分の合計の割合が25〜35重量%である、[項1]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 2] The ratio of the component (A) is 65 to 75% by weight, the ratio of the component (B) is 13 to 25% by weight, and the total ratio of the components (B) and (C) is 25 to 35% by weight. The crystal nucleating agent for granular polyolefin resin according to [1], which is
[項3] 前記(B)成分と(C)成分の合計量中に占める(B)成分の割合が35〜75重量%である、[項1]又は[項2]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 3] The granular polyolefin according to [Item 1] or [Item 2], wherein the proportion of the component (B) in the total amount of the component (B) and the component (C) is 35 to 75% by weight. Crystal nucleating agent for resin.
[項4] 前記(B)成分が、分子内に少なくとも水酸基1個を有していてもよい脂肪酸のモノグリセリドである[項1]〜[項3]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 4] The granular polyolefin resin according to any one of [Item 1] to [Item 3], wherein the component (B) is a monoglyceride of a fatty acid which may have at least one hydroxyl group in the molecule. Crystal nucleating agent.
[項5] 前記脂肪酸が、炭素数14〜22の飽和脂肪酸である[項4]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 5] The crystal nucleating agent for granular polyolefin resin according to [Item 4], wherein the fatty acid is a saturated fatty acid having 14 to 22 carbon atoms.
[項6] 前記飽和脂肪酸が、12−ヒドロキシステアリン酸、ステアリン酸及びベヘン酸からなる群より選ばれた1種又は2種以上の脂肪酸である[項5]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 6] The granular polyolefin resin according to [Item 5], wherein the saturated fatty acid is one or more fatty acids selected from the group consisting of 12-hydroxystearic acid, stearic acid, and behenic acid. Crystal nucleating agent.
[項7] 前記飽和脂肪酸が、ステアリン酸である[項6]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 7] The crystal nucleating agent for granular polyolefin resin according to [Item 6], wherein the saturated fatty acid is stearic acid.
[項8] 前記(C)成分が、炭素数14〜22の飽和脂肪酸のアルカリ又はアルカリ土類金属塩、ヒンダードフェノール系化合物、及び亜リン酸エステル系化合物からなる群より選ばれた1種又は2種以上の化合物である、[項1]〜[項7]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 8] The component (C) is one selected from the group consisting of an alkali or alkaline earth metal salt of a saturated fatty acid having 14 to 22 carbon atoms, a hindered phenol compound, and a phosphite compound. Alternatively, the crystal nucleating agent for the granular polyolefin resin according to any one of [Item 1] to [Item 7], which is a compound of two or more kinds.
[項9] 前記(C)成分が、ペンタエリトリトールテトラキス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオナート]及び/又はトリス(2,4−ジ−t−ブチルフェニル)ホスファイトである、[項8]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 9] The component (C) is pentaerythritol tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate] and / or tris (2,4-di-t-butylphenyl). ) The crystal nucleating agent for granular polyolefin resin according to [8], which is a phosphite.
[項10] 前記(C)成分が、ペンタエリトリトールテトラキス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオナート]である、[項9]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 10] The granular polyolefin-based resin according to item 9, wherein the component (C) is pentaerythritol tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate]. Crystal nucleating agent.
[項11] 前記加熱混合時の粉体温度が、50〜120℃である[項1]〜[項10]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 11] The crystal nucleating agent for granular polyolefin resin according to any one of [Item 1] to [Item 10], wherein the powder temperature during the heating and mixing is 50 to 120 ° C.
[項12] [項1]〜[項11]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤をコアとし、更にそのコアに(D)ポリオレフィン系樹脂用結晶核剤の粒子が付着した状態であることを特徴とする顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 12] The granular nucleating agent for polyolefin resin as defined in any one of [Item 1] to [Item 11] is used as a core, and (D) particles of the crystalline nucleating agent for polyolefin resin are attached to the core. A crystalline nucleating agent for a granular polyolefin resin, characterized in that
[項13] (D)成分の付着量が、コア部分の顆粒状ポリオレフィン系樹脂用結晶核剤100重量部に対して1〜20重量部である、[項12]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 13] The amount of the component (D) attached is 1 to 20 parts by weight with respect to 100 parts by weight of the crystal nucleating agent for the granular polyolefin resin in the core portion, and the granular polyolefin system according to [item 12]. Crystal nucleating agent for resins.
[項14] (D)成分の付着量が、コア部分の顆粒状ポリオレフィン系樹脂用結晶核剤100重量部に対して5〜15重量部である、[項13]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 14] The granular polyolefin-based material according to [Item 13], wherein the amount of the component (D) attached is 5 to 15 parts by weight based on 100 parts by weight of the crystal nucleating agent for the granular polyolefin-based resin in the core portion. Crystal nucleating agent for resins.
[項15] 顆粒状ポリオレフィン系樹脂用結晶核剤の安息角が40度以下であり、且つゆるめ嵩密度とかため嵩密度から求められる圧縮比が1.2以下である、[項1]〜[項14]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 15] The angle of repose of the crystal nucleating agent for granular polyolefin resin is 40 degrees or less, and the compression ratio obtained from the loose bulk density is 1.2 or less. Item 14] The crystal nucleating agent for a granular polyolefin resin according to any one of [14].
[項16] 安息角が35度以下であり、且つゆるめ嵩密度とかため嵩密度から求められる圧縮比が1.1以下である、[項15]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 16] The crystal nucleating agent for granular polyolefin resin according to [Item 15], which has a repose angle of 35 degrees or less and a compression ratio of 1.1 or less, which is obtained from the loose bulk density. .
[項17] JIS K0069(1992)に準拠した条件で行ったふるい分け試験において、目開き600μmのJIS試験用ふるい上の残存物の全重量に対する割合が10重量%以上である、[項1]〜[項16]の何れかに記載のポリオレフィン系樹脂用結晶核剤。 [Item 17] In the sieving test conducted under the conditions based on JIS K0069 (1992), the ratio of the residue on the JIS test sieve having an opening of 600 μm to the total weight is 10% by weight or more, [Item 1] to The crystal nucleating agent for polyolefin resin according to any one of [Item 16].
[項18] 前記(A)成分及び/又は(D)成分が、下記一般式(1)で示されるジアセタール系化合物である、[項1]〜[項17]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。
[項19] 前記一般式(1)において、R1及びR2が、同一又は異なって、メチル基又はエチル基であり、かつ、R3が水素原子であり、m及びnが1又は2の整数であり、pが1である、[項18]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 19] In the general formula (1), R 1 and R 2 are the same or different and each is a methyl group or an ethyl group, R 3 is a hydrogen atom, and m and n are 1 or 2. The crystal nucleating agent for granular polyolefin resin according to [Item 18], which is an integer and p is 1.
[項20] 前記一般式(1)において、R1及びR2が、同一又は異なって、プロピル基又はプロポキシ基であり、かつ、R3がプロピル基又はプロペニル基であり、m及びnが1であり、pが1である、[項18]に記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 20] In the general formula (1), R 1 and R 2 are the same or different and each is a propyl group or a propoxy group, R 3 is a propyl group or a propenyl group, and m and n are 1 And the crystal nucleating agent for granular polyolefin resin according to [Item 18], wherein p is 1.
[項21] 顆粒状ポリオレフィン系樹脂用結晶核剤が、加熱攪拌造粒物である、[項1]〜[項20]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤。 [Item 21] The crystal nucleating agent for granular polyolefin resin according to any one of [Item 1] to [Item 20], wherein the crystal nucleating agent for granular polyolefin resin is a heat-stir-granulated product.
[項22] 流動性の改良された顆粒状ポリオレフィン系樹脂用結晶核剤の製造方法であって、
(i)(A)ポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド、及び(C)100℃以上の融点を有する有機化合物を、粉体温度を(B)成分の融点と(C)成分の融点の間の温度範囲に制御しながら、攪拌造粒する工程を具備する製造方法。
[Item 22] A method for producing a crystal nucleating agent for a granular polyolefin resin, which has improved fluidity,
(I) (A) a crystal nucleating agent for polyolefin resin, (B) an organic acid monoglyceride, and (C) an organic compound having a melting point of 100 ° C. or higher, and the powder temperature is set to the melting point of the (B) component and (C). A manufacturing method comprising a step of stirring and granulating while controlling the temperature range between the melting points of the components.
[項23] 工程(i)における(A)成分の割合が60〜80重量%であり、(B)成分の割合が10〜30重量%であり、(B)成分と(C)成分の合計の割合が20〜40重量%であり、更に、(B)成分と(C)成分の合計量中に占める(B)成分の割合が30〜80重量%である、[項22]に記載の製造方法。 [Item 23] The proportion of the component (A) in the step (i) is 60 to 80% by weight, the proportion of the component (B) is 10 to 30% by weight, and the total of the components (B) and (C) is Is 20 to 40% by weight, and the proportion of the component (B) in the total amount of the components (B) and (C) is 30 to 80% by weight. Production method.
[項24] 工程(i)における(A)成分の割合が65〜75重量%であり、(B)成分の割合が13〜25重量%であり、(B)成分と(C)成分の合計の割合が25〜35重量%であり、更に、(B)成分と(C)成分の合計量中に占める(B)成分の割合が35〜75重量%である、[項23]に記載の製造方法。 [Item 24] The proportion of the component (A) in the step (i) is 65 to 75% by weight, the proportion of the component (B) is 13 to 25% by weight, and the total of the components (B) and (C) is Is 25 to 35% by weight, and the proportion of the component (B) in the total amount of the components (B) and (C) is 35 to 75% by weight. Production method.
[項25] [項22]〜[項24]の何れかに記載の工程(i)の後に、(ii)工程(i)で得られた顆粒状ポリオレフィン系樹脂用結晶核剤に、更に(D)ポリオレフィン系樹脂用結晶核剤を加えて、粉体温度を(B)成分の融点以上、工程(i)の粉体温度未満の温度範囲に制御しながら、加熱混合する工程を具備する製造方法。 [Item 25] After the step (i) according to any one of [Item 22] to [Item 24], (ii) the granular crystal nucleating agent for a polyolefin-based resin obtained in step (i), and further ( D) Production comprising a step of adding a crystal nucleating agent for polyolefin resin and heating and mixing while controlling the powder temperature in a temperature range not lower than the melting point of the component (B) and lower than the powder temperature in the step (i) Method.
[項26] 工程(ii)における(D)成分の配合量が、工程(i)で得られた顆粒状ポリオレフィン系樹脂用結晶核剤100重量部に対して、1〜20重量部である、[項25]に記載の製造方法。 [Item 26] The blending amount of the component (D) in the step (ii) is 1 to 20 parts by weight with respect to 100 parts by weight of the crystal nucleating agent for the granular polyolefin resin obtained in the step (i). The manufacturing method according to [item 25].
[項27] 工程(ii)における(D)成分の配合量が、工程(i)で得られた顆粒状ポリオレフィン系樹脂用結晶核剤100重量部に対して、5〜15重量部である、[項26]に記載の製造方法。 [Item 27] The blending amount of the component (D) in the step (ii) is 5 to 15 parts by weight with respect to 100 parts by weight of the crystal nucleating agent for the granular polyolefin resin obtained in the step (i). The manufacturing method according to [26].
[項28] 工程(i)における粉体温度が、(B)成分の融点以上、(C)成分の融点以下の範囲である、[項22]〜[項27]の何れかに記載の製造方法。 [Item 28] The production according to any one of [Item 22] to [Item 27], wherein the powder temperature in the step (i) is in the range from the melting point of the component (B) to the melting point of the component (C). Method.
[項29] 工程(ii)における粉体温度が、(B)成分の融点〜(B)成分の融点+50℃の範囲であり、且つ工程(i)の粉体温度未満である、[項25]〜[項28]の何れかに記載の製造方法。 [Item 29] The powder temperature in the step (ii) is in the range of the melting point of the component (B) to the melting point of the component (B) + 50 ° C., and is lower than the powder temperature of the step (i). ] The manufacturing method in any one of [item 28].
[項30] 前記(A)成分及び/又は(D)成分が、下記一般式(1)で示されるジアセタール系化合物である、[項22]〜[項29]の何れかに記載の製造方法。
[項31] 前記一般式(1)において、R1及びR2が、同一又は異なって、メチル基又はエチル基であり、かつ、R3が水素原子であり、m及びnが1又は2の整数であり、pが1である、[項30]に記載の製造方法。 [Item 31] In the general formula (1), R 1 and R 2 are the same or different and each is a methyl group or an ethyl group, R 3 is a hydrogen atom, and m and n are 1 or 2. The production method according to [Item 30], which is an integer and p is 1.
[項32] 前記一般式(1)において、R1及びR2が、同一又は異なって、プロピル基又はプロポキシ基であり、かつ、R3がプロピル基又はプロペニル基であり、m及びnが1であり、pが1である、[項30]に記載の製造方法。 [Item 32] In the general formula (1), R 1 and R 2 are the same or different and each is a propyl group or a propoxy group, R 3 is a propyl group or a propenyl group, and m and n are 1 And the manufacturing method is as set forth in [claim 30], wherein p is 1.
[項33] 前記(B)成分が、分子内に少なくとも水酸基1個を有していてもよい脂肪酸のモノグリセリドである[項22]〜[項32]の何れかに記載の製造方法。 [Item 33] The production method according to any one of [Item 22] to [Item 32], wherein the component (B) is a monoglyceride of a fatty acid which may have at least one hydroxyl group in the molecule.
[項34] 前記脂肪酸が、炭素数14〜22の飽和脂肪酸である[項33]に記載の製造方法。 [Item 34] The production method according to [Item 33], wherein the fatty acid is a saturated fatty acid having 14 to 22 carbon atoms.
[項35] 前記飽和脂肪酸が、12−ヒドロキシステアリン酸、ステアリン酸及びベヘン酸からなる群より選ばれた1種又は2種以上の脂肪酸である[項34]に記載の製造方法。 [Item 35] The production method according to [Item 34], wherein the saturated fatty acid is one or more fatty acids selected from the group consisting of 12-hydroxystearic acid, stearic acid, and behenic acid.
[項36] 前記飽和脂肪酸が、ステアリン酸である[項35]に記載の製造方法。 [Item 36] The production method according to [Item 35], wherein the saturated fatty acid is stearic acid.
[項37] 前記(C)成分が、炭素数14〜22の飽和脂肪酸のアルカリ又はアルカリ土類金属塩、ヒンダードフェノール系化合物、及び亜リン酸エステル系化合物からなる群より選ばれた1種又は2種以上の化合物である、[項22]〜[項35]の何れかに記載の製造方法。 [Item 37] The component (C) is one selected from the group consisting of an alkali or alkaline earth metal salt of a saturated fatty acid having 14 to 22 carbon atoms, a hindered phenol compound, and a phosphite compound. Alternatively, the production method according to any one of [Item 22] to [Item 35], which is two or more compounds.
[項38] 前記(C)成分が、ペンタエリトリトールテトラキス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオナート]及び/又はトリス(2,4−ジ−t−ブチルフェニル)ホスファイトである、[項37]に記載の製造方法。 [Item 38] The component (C) is pentaerythritol tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate] and / or tris (2,4-di-t-butylphenyl). ) The production method according to [Item 37], which is a phosphite.
[項39] 前記(C)成分が、ペンタエリトリトールテトラキス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオナート]である、[項38]に記載の製造方法。 [Item 39] The production method according to [Item 38], wherein the component (C) is pentaerythritol tetrakis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate].
[項40] ポリオレフィン系樹脂と[項1]〜[項21]の何れかに記載の顆粒状ポリオレフィン系樹脂用結晶核剤を含んでなるポリオレフィン系樹脂組成物。 [Item 40] A polyolefin resin composition comprising a polyolefin resin and the crystal nucleating agent for granular polyolefin resin according to any one of [Item 1] to [Item 21].
[項41] 顆粒状ポリオレフィン系樹脂用結晶核剤の含有量が、ポリオレフィン系樹脂100重量部に対して、0.001〜10重量部である、[項40]に記載のポリオレフィン系樹脂組成物。 [Item 41] The polyolefin resin composition according to item 40, wherein the content of the crystal nucleating agent for granular polyolefin resin is 0.001 to 10 parts by weight relative to 100 parts by weight of the polyolefin resin. .
[項42] 前記含有量が、0.01〜5重量部である、[項41]に記載のポリオレフィン系樹脂組成物。 [Item 42] The polyolefin-based resin composition according to [Item 41], wherein the content is 0.01 to 5 parts by weight.
[項43] [項40]〜[項42]の何れかに記載のポリオレフィン系樹脂組成物を原料とするポリオレフィン系樹脂成形体。 [Item 43] A polyolefin-based resin molded product using the polyolefin-based resin composition according to any one of [Item 40] to [Item 42] as a raw material.
[項44] (A)ポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド及び(C)100℃以上の融点を有する有機化合物を、粉体温度を(B)成分の融点以上、(C)成分の融点未満の温度範囲に制御しながら、攪拌混合することにより顆粒状とする、ポリオレフィン系樹脂用結晶核剤の流動性改良方法。 [Item 44] (A) A crystal nucleating agent for a polyolefin resin, (B) an organic acid monoglyceride and (C) an organic compound having a melting point of 100 ° C. or higher, a powder temperature of the melting point of the component (B) or higher, (C) ) A method for improving the fluidity of a crystal nucleating agent for a polyolefin resin, which comprises granulating by stirring and mixing while controlling the temperature range below the melting point of the component.
[項45] 前記方法において顆粒状としたポリオレフィン系樹脂用結晶核剤と更に添加された(D)ポリオレフィン系樹脂用結晶核剤とを、粉体温度を(B)成分の融点の融点以上、前記の撹拌混合時の粉体温度未満の温度範囲に制御しながら、攪拌混合することにより顆粒状とする、[項44]に記載の流動性改良方法。 [Item 45] The crystal nucleating agent for a polyolefin resin, which has been granulated in the above method, and the crystal nucleating agent for a polyolefin resin (D), which are further added, have a powder temperature of not less than the melting point of the component (B), The method for improving fluidity according to [Item 44], wherein granules are formed by stirring and mixing while controlling the temperature range to be lower than the powder temperature during the stirring and mixing.
本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、非常に流動性に優れており、生産性の向上などに大きく寄与することができる。また、本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、特にジアセタール系化合物等において非常に重要であるポリオレフィン系樹脂中での分散性や溶解性についても、従来の結晶核剤と同等かそれ以上の性能を有しており、ポリオレフィン系樹脂用結晶核剤として非常に優れた性能を発揮することができる。従って、本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、様々な用途で幅広く使用することが可能であり、得られた成形体は非常に優れた透明性を有しており、多くの用途で有用である。更に、工程(ii)を具備する製造方法により製造された本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、バインダー効果を有する特定の化合物に起因するケーキング等の問題も解消され、より幅広い用途への応用が可能である。 The crystal nucleating agent for a granular polyolefin resin of the present invention has extremely excellent fluidity and can greatly contribute to the improvement of productivity. Further, the crystal nucleating agent for the granular polyolefin-based resin of the present invention has the same or similar dispersibility and solubility as the conventional crystal nucleating agent in the polyolefin-based resin which is very important particularly in the diacetal compound and the like. It has the above-mentioned properties and can exhibit extremely excellent properties as a crystal nucleating agent for polyolefin resin. Therefore, the crystal nucleating agent for granular polyolefin resin of the present invention can be widely used in various applications, and the obtained molded article has very excellent transparency and has many applications. Useful in. Furthermore, the crystal nucleating agent for a granular polyolefin resin of the present invention produced by the production method comprising the step (ii) eliminates problems such as caking caused by a specific compound having a binder effect, and has a wider range of applications. Can be applied to.
<顆粒状ポリオレフィン系樹脂用結晶核剤>
本発明の結晶核剤は顆粒状であることを特徴とし、その顆粒状結晶核剤は、(A)通常の製造方法により得られたポリオレフィン系樹脂用結晶核剤の粉末に、所定量の(B)有機酸モノグリセリドと(C)100℃以上の融点を有する有機化合物を加えて、粉体温度を(B)成分の融点以上(C)成分の融点以下の温度範囲に制御しながら、加熱混合することにより得ることができる。前記加熱混合とは、各成分を加熱下で混合することを意味し、その混合方法は、本発明の効果が得られる限り、特に混合方法に制約はないが、好ましい方法としては、攪拌による混合方法(撹拌混合)が推奨される。即ち、攪拌により混合しながら造粒する方法(撹拌造粒)が本発明の目的の顆粒状とする方法として特に推奨される。加熱下で攪拌造粒された顆粒状ポリオレフィン系樹脂用結晶核剤(加熱攪拌造粒物)は、流動性等の性能面で特に優位となる。
<Crystal Nucleating Agent for Granular Polyolefin Resin>
The crystal nucleating agent of the present invention is characterized in that it is in the form of granules, and the granular crystal nucleating agent is (A) a powder of the crystal nucleating agent for a polyolefin resin obtained by an ordinary production method, in a predetermined amount ( B) Mixing with an organic acid monoglyceride and (C) an organic compound having a melting point of 100 ° C. or higher, while controlling the powder temperature within a temperature range of the melting point of the (B) component or higher and the melting point of the (C) component or lower, and mixing by heating. It can be obtained by The heating and mixing means mixing the components under heating, and the mixing method is not particularly limited as long as the effect of the present invention can be obtained, but a preferable method is mixing by stirring. Method (stirring mixing) is recommended. That is, a method of granulating while mixing by stirring (stir granulation) is particularly recommended as a method of forming a granule for the purpose of the present invention. The crystal nucleating agent for a granular polyolefin-based resin (heat-stir-granulated material) that is agitated and granulated under heating is particularly superior in terms of performance such as fluidity.
本発明において、上記効果が得られる理由を確認することは困難であったが、上記条件で調製することにより、完全に融解した(B)成分は、(A)成分の凝集した粒子中に均一に浸透して、優れたバインダー効果を示し、更に完全に融解していない(C)成分を共存させることにより、(B)成分のバインダー効果を調整しているものと推測される。即ち、(B)成分だけでは、一般に知られている粒状化による分散性低下の懸念があったが、(C)成分を共存させることにより、バインダー効果が調整され、分散性の低下の懸念がなくなったものと推測される。また、融点の高い(C)成分を共存させることにより、ケーキング等の懸念も減少されているものと推測される。以上の推測から、本発明において、その混合条件及び混合比率が非常に重要な要件となっているものと考えられる。 In the present invention, it was difficult to confirm the reason why the above effects were obtained, but by preparing under the above conditions, the completely melted component (B) was homogeneous in the aggregated particles of the component (A). It is presumed that the binder effect of the component (B) is adjusted by making the component (C) coexist with the component (C) which does not completely melt, by coexisting with the component (C). That is, the component (B) alone had a concern that the dispersibility may be reduced due to the generally known granulation, but the coexistence of the component (C) may adjust the binder effect and may cause a decrease in the dispersibility. It is supposed to have disappeared. Moreover, it is presumed that coexistence of the component (C) having a high melting point reduces concerns such as caking. From the above speculation, it is considered that the mixing condition and mixing ratio are very important requirements in the present invention.
また、用途によっては上記の条件でもバインダー効果を有する(B)成分に起因するケーキング等の問題が生じる場合があり、その場合には、上記で得られた本発明の顆粒状結晶核剤に、更に通常の製造方法により得られた(D)ポリオレフィン系樹脂用結晶核剤の粉末を加えて、粉体温度を(B)成分の融点以上、前記第一段階のコア部分を調製した時の粉体温度未満の温度範囲に制御しながら、攪拌混合することにより、該ケーキング等の問題も解消された顆粒状ポリオレフィン系樹脂用結晶核剤を得ることができる。一般的に、樹脂添加剤組成物におけるケーキングは、融点の低い成分、即ち本発明においては(B)成分に起因するものと考えられる。従って、最も効果的な方法はその成分の量を減らすことであるが、その場合、十分な顆粒化ができず、また流動性や分散性などの本来目的とする性能向上が不十分となり、近年の厳しい要求を満足することが難しくなってきている。そこで、本発明者らは本発明の目的の流動性や分散性を維持しつつ、ケーキング等の問題を解消する方法を種々検討した結果、その理由は明確ではないが、上記の様な態様とすることによりケーキング等の問題が解消できるという結論に至った。この場合、その境界が不鮮明であり目視等で確認することは困難であるが、加えた(D)成分の多くが、前記顆粒状結晶核剤の表面に付着した状態であるものと推測され、その様な状態であることがケーキングを抑えるために特に重要であろうと考えられる。 In addition, depending on the application, there may be a problem such as caking due to the component (B) having a binder effect even under the above conditions. In that case, the granular crystal nucleating agent of the present invention obtained above, Further, (D) a powder of a crystal nucleating agent for a polyolefin resin obtained by a usual production method is added, and a powder temperature is equal to or higher than the melting point of the component (B). By stirring and mixing while controlling the temperature range below the body temperature, it is possible to obtain a crystal nucleating agent for a granular polyolefin resin in which the problems such as the caking are solved. Generally, caking in a resin additive composition is considered to be caused by a component having a low melting point, that is, component (B) in the present invention. Therefore, the most effective method is to reduce the amount of the component, but in that case, sufficient granulation cannot be achieved, and the originally desired performance improvement such as fluidity and dispersibility becomes insufficient, and in recent years It is becoming difficult to meet the strict demands of. Therefore, the present inventors have studied various methods of solving the problems such as caking while maintaining the fluidity and dispersibility of the object of the present invention, the reason for which is not clear, but as described above. It was concluded that by doing so, problems such as caking can be solved. In this case, the boundary is unclear and it is difficult to visually confirm, but it is presumed that most of the added component (D) is attached to the surface of the granular crystal nucleating agent, It is considered that such a state would be particularly important for suppressing caking.
(A)成分及び(D)成分であるポリオレフィン系樹脂用結晶核剤の形状は、本発明の効果を奏する限り、特に制約はないが、好ましくはレーザー回折式粒度分布測定で求めた平均粒径が0.01〜15μmの粉末状であることが、より好ましくは0.1〜10μmの粉末状であることが、特に推奨される。平均粒径を0.01μm以上にすることにより、顆粒化がし易くなる傾向にあり、平均粒径を15μm以下にすることにより、本発明の顆粒状結晶核剤のポリオレフィン系樹脂中への分散性や溶解性に好影響を及ぼす傾向が認められる。 The shape of the crystal nucleating agent for the polyolefin-based resin, which is the component (A) and the component (D), is not particularly limited as long as the effects of the present invention are exhibited, but preferably the average particle diameter determined by laser diffraction particle size distribution measurement. Is particularly preferably 0.01 to 15 μm, more preferably 0.1 to 10 μm. When the average particle size is 0.01 μm or more, granulation tends to be easy, and when the average particle size is 15 μm or less, the granular crystal nucleating agent of the present invention is dispersed in a polyolefin resin. There is a tendency that it positively affects the solubility and solubility.
本発明の顆粒状結晶核剤は、流動性の観点より顆粒状であることが肝要であり、好ましくはJIS K0069(1992)に準拠した条件で行ったふるい分け試験において、目開き600μmのJIS試験用ふるい上の残存物の全重量に対する割合が10重量%以上、より好ましくは20重量%以上であることが推奨される。ここで、少ない(B)成分や(C)成分の使用量で上記顆粒状結晶核剤の粒径に調整するためには、攪拌造粒法が最も有利であった。 It is essential that the granular crystal nucleating agent of the present invention is in the form of granules from the viewpoint of fluidity, and is preferably used for the JIS test having a mesh size of 600 μm in the sieving test conducted under the conditions according to JIS K0069 (1992). It is recommended that the ratio of the residue on the sieve to the total weight is 10% by weight or more, more preferably 20% by weight or more. Here, the stirring granulation method was most advantageous in order to adjust the particle size of the granular crystal nucleating agent with a small amount of the component (B) or the component (C) used.
また、本発明の顆粒状結晶核剤は、流動性の改良の観点より、その安息角が好ましくは40度以下、より好ましくは35度以下であることが推奨される。安息角が40度を超えると十分な流動性が得られ難くなる傾向にある。 The angle of repose of the granular crystal nucleating agent of the present invention is preferably 40 degrees or less, more preferably 35 degrees or less from the viewpoint of improving fluidity. If the angle of repose exceeds 40 degrees, sufficient fluidity tends to be difficult to obtain.
さらに、本発明の顆粒状結晶核剤は、ゆるめ嵩密度とかため嵩密度から求められる圧縮比(かため嵩密度/ゆるめ嵩密度)が1.2以下であることが推奨される。一般に、圧縮比が1に近いほど流動性に優れる傾向にあり、本発明でも通常の粉末状の結晶核剤に比べて圧縮比が1に近くなっており、そのことが流動性の改良に効果をもたらしているものと推測される。 Further, the granular crystal nucleating agent of the present invention is recommended to have a compression ratio (hard bulk density / loose bulk density) of 1.2 or less, which is obtained from the loose bulk density and the firm bulk density. Generally, the closer the compression ratio is to 1, the more excellent the fluidity is, and in the present invention, the compression ratio is closer to 1 as compared with the usual powdery crystal nucleating agent, which is effective in improving the fluidity. It is presumed that it has brought about.
上記レーザー回折式粒度分布測定は、汎用の装置を用いて、汎用の方法・条件により測定することができる。例えば、レーザー回折式粒度分布計(マルバーンインスツルメンツ社製、「マスターサイザー3000」)を用いて、湿式測定セル中で十分に撹拌混合することで、分散剤として界面活性剤を加えた水溶液中に試料を分散させ、続いて、得られた混合物を装置内で更に撹拌、循環させながら、超音波を当てて装置内にて十分に均一に分散させた後、超音波を当てながら試料の粒度分布を測定することができる。得られた粒度分布より平均粒径、即ち体積基準累積50%粒径(メジアン径:d50)を求めることができる。 The laser diffraction particle size distribution measurement can be carried out by a general-purpose method and conditions using a general-purpose device. For example, by using a laser diffraction type particle size distribution meter ("Mastersizer 3000" manufactured by Malvern Instruments, Inc.), the sample is placed in an aqueous solution containing a surfactant as a dispersant by thoroughly stirring and mixing in a wet measurement cell. Then, while further agitating and circulating the obtained mixture in the device, ultrasonic waves are applied to disperse the mixture evenly in the device, and then the particle size distribution of the sample is changed by applying ultrasonic waves. Can be measured. From the obtained particle size distribution, the average particle size, that is, the volume-based cumulative 50% particle size (median size: d50) can be determined.
また、上記ふるい分け試験は、JIS K0069(1992)に準拠して、JIS規格に適合した汎用のふるいを用いて、測定することができる。具体的には、JIS K0069(1992)の6.1に準拠した条件で、ふるい分け試験を行い、目開き600μmのJIS試験用ふるい上の残存物の重量を測定し、試験に用いた試料の全重量に対する割合を求めた。 In addition, the sieving test can be measured using a general-purpose sieve that conforms to the JIS standard according to JIS K0069 (1992). Specifically, a sieving test is performed under the conditions according to JIS K0069 (1992) 6.1, and the weight of the residue on the JIS test sieve having an opening of 600 μm is measured, and all the samples used for the test are measured. The ratio to the weight was calculated.
(A)成分;ポリオレフィン系樹脂用結晶核剤、及び
(D)成分;ポリオレフィン系樹脂用結晶核剤
(A)成分であるポリオレフィン系樹脂用結晶核剤及び(D)成分であるポリオレフィン系樹脂用結晶核剤としては、例えば、ジアセタール系化合物、カルボン酸塩系化合物、リン酸エステル塩系化合物、アミド系化合物、ロジン系化合物などが例示され、(A)成分と(D)成分の種類と同一又は異なっても良いが、好ましくは(A)成分(D)成分が同じ種類であることが推奨される。なかでも、上記ジアセタール系化合物において、本発明の効果が最も顕著である。ただし、その種類は、本発明の効果を奏する限り、特に限定されるものではない。
(A) component; a crystal nucleating agent for polyolefin resin, and
Component (D): Crystal nucleating agent for polyolefin resin (A) The crystal nucleating agent for polyolefin resin (A) and the crystal nucleating agent for polyolefin resin (D) are, for example, diacetal compounds and carboxylic acids. Examples thereof include salt compounds, phosphate ester salt compounds, amide compounds, rosin compounds, and the like, and the types of the component (A) and the component (D) may be the same or different, but the component (A) ( It is recommended that component D) be of the same type. Among them, the effect of the present invention is most remarkable in the above diacetal compound. However, the type is not particularly limited as long as the effects of the present invention are exhibited.
上記ジアセタール系化合物としては、具体的には、下記一般式(1)で示されるジアセタール化合物が例示される。
上記ジアセタール化合物の中でも、更に好ましい化合物としては、例えば、上記一般式(1)中のR1及びR2が、同一又は異なって、メチル基又はエチル基であり、かつ、R3が水素原子であり、m及びnが1又は2の整数であり、pが1である化合物や、上記一般式(1)中のR1及びR2がプロピル基又はプロピルオキシ基であり、かつ、R3がプロピル基又はプロペニル基であり、m及びnが1であり、pが1である化合物などが挙げられる。 Among the above diacetal compounds, more preferable compounds include, for example, R 1 and R 2 in the general formula (1), which are the same or different, are a methyl group or an ethyl group, and R 3 is a hydrogen atom. And m and n are integers of 1 or 2, and p is 1, or R 1 and R 2 in the general formula (1) are propyl groups or propyloxy groups, and R 3 is Examples thereof include a propyl group or a propenyl group, m and n are 1, and p is 1.
また、次の様な化合物も更に好ましい化合物として例示することができる;上記一般式(1)において、R1及びR2がプロピル基又はプロピルオキシ基であり、かつ、R3がプロピル基又はプロペニル基であり、m及びnが1であり、pが1である化合物。 Further, the following compounds can be exemplified as more preferable compounds; in the above general formula (1), R 1 and R 2 are propyl groups or propyloxy groups, and R 3 is a propyl group or propenyl. A compound, wherein m and n are 1 and p is 1.
上記ジアセタール系化合物の具体的な態様としては、次の様な化合物が例示される。1,3:2,4−ジ−O−ベンジリデン−D−ソルビトール、1,3:2,4−ビス−O−(メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(エチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−エチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−エチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−イソプロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−イソプロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−イソプロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−n−プロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−n−プロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−n−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−n−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−n−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−t−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−t−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−t−ブチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,3’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,5’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,6’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,5’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,3’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,4’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,5’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,6’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,5’−ジエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,4’,5’−トリメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’,5’−トリメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(2’,4’,5’−トリエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’,5’−トリエチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−メトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−メトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−メトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−エトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−エトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−エトキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−イソプロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−イソプロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−イソプロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−n−プロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−n−プロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−n−プロポキシベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−メトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−メトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−メトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−エトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−エトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−エトキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−イソプロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−イソプロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−イソプロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−n−プロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−n−プロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−n−プロポキシカルボニルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−フルオロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−フルオロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−フルオロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−クロロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−クロロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−クロロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(o−ブロモベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(m−ブロモベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−ブロモベンジリデン)−D−ソルビトール、1,3−O−ベンジリデン−2,4−O−(p−メチルベンジリデン)−D−ソルビトール、1,3−O−(p−メチルベンジリデン)−2,4−O−ベンジリデン−D−ソルビトール、1,3−O−ベンジリデン−2,4−O−(p−エチルベンジリデン)−D−ソルビトール、1,3−O−(p−エチルベンジリデン)−2,4−O−ベンジリデン−D−ソルビトール、1,3−O−ベンジリデン−2,4−O−(p−クロロベンジリデン)−D−ソルビトール、1,3−O−(p−クロロベンジリデン)−2,4−O−ベンジリデン−D−ソルビトール、1,3−O−ベンジリデン−2,4−O−(2’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3−O−(2’,4’−ジメチルベンジリデン)−2,4−O−ベンジリデン−D−ソルビトール、1,3−O−ベンジリデン−2,4−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3−O−(3’,4’−ジメチルベンジリデン)−2,4−O−ベンジリデン−D−ソルビトール、1,3−O−(p−メチルベンジリデン)−2,4−O−(p−エチルベンジリデン)−D−ソルビトール、1,3−O−(p−エチルベンジリデン)−2,4−O−(p−メチルベンジリデン)−D−ソルビトール、1,3−O−(p−メチルベンジリデン)−2,4−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3−O−(3’,4’−ジメチルベンジリデン)−2,4−O−p−メチルベンジリデン−D−ソルビトール、1,3−O−(p−エチルベンジリデン)−2,4−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3−O−(3’,4’−ジメチルベンジリデン)−2,4−O−p−エチルベンジリデン−D−ソルビトール、1,3−O−(p−メチルベンジリデン)−2,4−O−(p−クロロベンジリデン)−D−ソルビトール、1,3−O−(p−クロロベンジリデン)−2,4−O−(p−メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−ベンジリデン−1−メチルソルビトール、1,3:2,4−ビス−O−(p−メチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジメチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジエチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−メトキシベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(p−メトキシカルボニルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−フルオロベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−(3’−ブロモ−4’−エチルベンジリデン)−1−メチルソルビトール、1,3:2,4−ビス−O−ベンジリデン−1−エチルソルビトール、1,3:2,4−ビス−O−(p−メチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジメチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジエチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジエチルベンジリデ
ン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジエチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジエチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジエチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジエチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−メトキシベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(p−メトキシカルボニルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−フルオロベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−(3’−ブロモ−4’−エチルベンジリデン)−1−エチルソルビトール、1,3:2,4−ビス−O−ベンジリデン−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−メチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジメチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−メトキシベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−メトキシカルボニルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−エトキシカルボニルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−プロポキシカルボニルベンジリデン)−1−n−プロピルソルビトール、1,3−O−(p−n−プロピルベンジリデン)−2,4−O−(p−プロポキシベンジリデン)−1−n−プロピルソルビトール、1,3−O−(p−プロポキシベンジリデン)−2,4−O−(p−n−プロピルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−フルオロベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’−ブロモ−4’−エチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−プロペニルソルビトール、1,3:2,4−ビス−O−(p−エトキシカルボニルベンジリデン)−1−プロペニルソルビトール、1,3:2,4−ビス−O−(p−プロポキシカルボニルベンジリデン)−1−プロペニルソルビトール、1,3−O−(p−n−プロピルベンジリデン)−2,4−O−(p−プロポキシベンジリデン)−1−プロペニルソルビトール、1,3−O−(p−プロポキシベンジリデン)−2,4−O−(p−n−プロピルベンジリデン)−1−プロペニルソルビトール、1,3:2,4−ビス−O−ベンジリデン−1−アリルソルビトール、1,3:2,4−ビス−O−(p−メチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジメチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,3’−ジエチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,4’−ジエチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,5’−ジエチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(2’,6’−ジエチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジエチルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(p−エトキシカルボニルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(p−プロポキシカルボニルベンジリデン)−1−アリルソルビトール、1,3−O−(p−n−プロピルベンジリデン)−2,4−O−(p−プロポキシベンジリデン)−1−アリルソルビトール、1,3−O−(p−プロポキシベンジリデン)−2,4−O−(p−n−プロピルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’,5’−ジエチルベンジリデン)−1−n−プロピルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−メトキシベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(p−メトキシカルボニルベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’−メチル−4’−フルオロベンジリデン)−1−アリルソルビトール、1,3:2,4−ビス−O−(3’−ブロモ−4’−エチルベンジリデン)−1−アリルソルビトール等が例示される。
Specific examples of the diacetal compound include the following compounds. 1,3: 2,4-di-O-benzylidene-D-sorbitol, 1,3: 2,4-bis-O- (methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O -(O-Methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p- Methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (ethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (o-ethylbenzylidene) -D- Sorbitol, 1,3: 2,4-bis-O- (m-ethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -D-sorbitol, 1, 3: 2,4-bis-O- (o-isopropylate Benzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-isopropylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-isopropylbenzylidene) -D. -Sorbitol, 1,3: 2,4-bis-O- (on-propylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (mn-propylbenzylidene) -D -Sorbitol, 1,3: 2,4-bis-O- (pn-propylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (on-butylbenzylidene) -D -Sorbitol, 1,3: 2,4-bis-O- (mn-butylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (pn-butylbenzylidene) -D -Sorbitol, 1,3: 2 -Bis-O- (o-t-butylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-t-butylbenzylidene) -D-sorbitol, 1,3: 2,4 -Bis-O- (pt-butylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O -(2 ', 3'-Dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2', 4'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4 -Bis-O- (2 ', 5'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2', 6'-dimethylbenzylidene) -D-sorbitol, 1,3 : 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D Sorbitol, 1,3: 2,4-bis-O- (3 ', 5'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2', 3'-diethylbenzylidene) ) -D-sorbitol, 1,3: 2,4-bis-O- (2 ', 4'-diethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2', 5) '-Diethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2', 6'-diethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- ( 3 ', 4'-Diethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (3', 5'-diethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis -O- (2 ', 4', 5'-trimethylbenzylidene) -D-sorbitol, 1,3: 2 4-bis-O- (3 ', 4', 5'-trimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (2 ', 4', 5'-triethylbenzylidene)- D-sorbitol, 1,3: 2,4-bis-O- (3 ', 4', 5'-triethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (o-methoxy) Benzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-methoxybenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-methoxybenzylidene) -D -Sorbitol, 1,3: 2,4-bis-O- (o-ethoxybenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-ethoxybenzylidene) -D-sorbitol, 1 , 3: 2,4-bis-O- (p-ethoxybenzili ) -D-sorbitol, 1,3: 2,4-bis-O- (o-isopropoxybenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-isopropoxybenzylidene). -D-sorbitol, 1,3: 2,4-bis-O- (p-isopropoxybenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (on-propoxybenzylidene)- D-sorbitol, 1,3: 2,4-bis-O- (mn-propoxybenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (pn-propoxybenzylidene)- D-sorbitol, 1,3: 2,4-bis-O- (o-methoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-methoxycarbonylbenzylidene) -D- Sorbito 1,3: 2,4-bis-O- (p-methoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (o-ethoxycarbonylbenzylidene) -D-sorbitol , 1,3: 2,4-bis-O- (m-ethoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-ethoxycarbonylbenzylidene) -D-sorbitol, 1 , 3: 2,4-bis-O- (o-isopropoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-isopropoxycarbonylbenzylidene) -D-sorbitol, 1 , 3: 2,4-bis-O- (p-isopropoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (on-propoxycarbonyl) Benzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-n-propoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (pn-). Propoxycarbonylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (o-fluorobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-fluorobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-fluorobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (o-chlorobenzylidene) -D-sorbitol , 1,3: 2,4-bis-O- (m-chlorobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-chlorobenzylidene) -D-sorbitol, 1,3 : 2, -Bis-O- (o-bromobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (m-bromobenzylidene) -D-sorbitol, 1,3: 2,4-bis-O -(P-Bromobenzylidene) -D-sorbitol, 1,3-O-benzylidene-2,4-O- (p-methylbenzylidene) -D-sorbitol, 1,3-O- (p-methylbenzylidene)- 2,4-O-benzylidene-D-sorbitol, 1,3-O-benzylidene-2,4-O- (p-ethylbenzylidene) -D-sorbitol, 1,3-O- (p-ethylbenzylidene)- 2,4-O-benzylidene-D-sorbitol, 1,3-O-benzylidene-2,4-O- (p-chlorobenzylidene) -D-sorbitol, 1,3-O- (p-chlorobenzylidene)- Two 4-O-benzylidene-D-sorbitol, 1,3-O-benzylidene-2,4-O- (2 ', 4'-dimethylbenzylidene) -D-sorbitol, 1,3-O- (2', 4) '-Dimethylbenzylidene) -2,4-O-benzylidene-D-sorbitol, 1,3-O-benzylidene-2,4-O- (3', 4'-dimethylbenzylidene) -D-sorbitol, 1,3 -O- (3 ', 4'-dimethylbenzylidene) -2,4-O-benzylidene-D-sorbitol, 1,3-O- (p-methylbenzylidene) -2,4-O- (p-ethylbenzylidene) ) -D-sorbitol, 1,3-O- (p-ethylbenzylidene) -2,4-O- (p-methylbenzylidene) -D-sorbitol, 1,3-O- (p-methylbenzylidene) -2. , 4-O- (3 ', 4'-di Methylbenzylidene) -D-sorbitol, 1,3-O- (3 ′, 4′-dimethylbenzylidene) -2,4-Op-methylbenzylidene-D-sorbitol, 1,3-O- (p-ethyl) Benzylidene) -2,4-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol, 1,3-O- (3', 4'-dimethylbenzylidene) -2,4-Op-ethyl. Benzylidene-D-sorbitol, 1,3-O- (p-methylbenzylidene) -2,4-O- (p-chlorobenzylidene) -D-sorbitol, 1,3-O- (p-chlorobenzylidene) -2. , 4-O- (p-methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (3 ', 4'-dichlorobenzylidene) -D-sorbitol, 1,3: 2,4 -Bis-O-benzylidene-1 Methylsorbitol, 1,3: 2,4-bis-O- (p-methylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -1-methylsorbitol , 1,3: 2,4-bis-O- (pn-propylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2 ′, 3′-dimethylbenzylidene)- 1-Methylsorbitol, 1,3: 2,4-bis-O- (2 ', 4'-dimethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2', 5 '-Dimethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2', 6'-dimethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O -(3 ', 4'-Dimethylbenzylidene) -1 Methylsorbitol, 1,3: 2,4-bis-O- (3 ', 5'-dimethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2', 3'- Diethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2 ′, 4′-diethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- ( 2 ', 5'-Diethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (2', 6'-diethylbenzylidene) -1-methylsorbitol, 1,3: 2,4 -Bis-O- (3 ', 4'-diethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (3', 5'-diethylbenzylidene) -1-methylsorbitol, 1 , 3: 2,4-bis-O- (3'-methyl-4'-me Xybenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (3 ′, 4′-dichlorobenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- ( p-methoxycarbonylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O- (3′-methyl-4′-fluorobenzylidene) -1-methylsorbitol, 1,3: 2,4- Bis-O- (3'-bromo-4'-ethylbenzylidene) -1-methylsorbitol, 1,3: 2,4-bis-O-benzylidene-1-ethylsorbitol, 1,3: 2,4-bis -O- (p-methylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O -(Pn-propy Rubenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (2 ′, 3′-dimethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- ( 2 ', 4'-Dimethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (2', 5'-dimethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4 -Bis-O- (2 ', 6'-dimethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (3', 4'-dimethylbenzylidene) -1-ethylsorbitol, 1 , 3: 2,4-bis-O- (3 ', 5'-dimethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (2', 3'-diethylbenzylidene)- 1-ethylsorbitol, 1,3: 2,4-bis-O- 2 ', 4'-Diethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (2', 5'-diethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4 -Bis-O- (2 ', 6'-diethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (3', 4'-diethylbenzylidene) -1-ethylsorbitol, 1 , 3: 2,4-bis-O- (3 ′, 5′-diethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (3′-methyl-4′-methoxybenzylidene) ) -1-Ethylsorbitol, 1,3: 2,4-bis-O- (3 ', 4'-dichlorobenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (p- Methoxycarbonylbenzylidene) -1-ethylsorbitol 1,3: 2,4-bis-O- (3'-methyl-4'-fluorobenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O- (3'-bromo-4 ' -Ethylbenzylidene) -1-ethylsorbitol, 1,3: 2,4-bis-O-benzylidene-1-n-propylsorbitol, 1,3: 2,4-bis-O- (p-methylbenzylidene)- 1-n-propyl sorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- (pn- Propylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- (2 ′, 3′-dimethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis -O- (2 ', 4'-dimethylbenzylidene)- 1-n-propyl sorbitol, 1,3: 2,4-bis-O- (2 ', 5'-dimethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- ( 2 ', 6'-Dimethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- (3', 4'-dimethylbenzylidene) -1-n-propyl sorbitol, 1,3 : 2,4-bis-O- (3 ', 5'-dimethylbenzylidene) -1-n-propylsorbitol, 1,3: 2,4-bis-O- (2', 3'-diethylbenzylidene)- 1-n-propyl sorbitol, 1,3: 2,4-bis-O- (2 ', 4'-diethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- ( 2 ', 5'-diethylbenzylidene) -1-n-propyl sorbitol , 1,3: 2,4-bis-O- (2 ′, 6′-diethylbenzylidene) -1-n-propylsorbitol, 1,3: 2,4-bis-O- (3 ′, 4′- Diethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- (3 ′, 5′-diethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis -O- (3'-methyl-4'-methoxybenzylidene) -1-n-propylsorbitol, 1,3: 2,4-bis-O- (3 ', 4'-dichlorobenzylidene) -1-n- Propylsorbitol, 1,3: 2,4-bis-O- (p-methoxycarbonylbenzylidene) -1-n-propylsorbitol, 1,3: 2,4-bis-O- (p-ethoxycarbonylbenzylidene)- 1-n-propyl sorbitol, 1,3 2,4-bis-O- (p-propoxycarbonylbenzylidene) -1-n-propylsorbitol, 1,3-O- (pn-propylbenzylidene) -2,4-O- (p-propoxybenzylidene) -1-n-Propylsorbitol, 1,3-O- (p-propoxybenzylidene) -2,4-O- (pn-propylbenzylidene) -1-n-propylsorbitol, 1,3: 2,4 -Bis-O- (3'-methyl-4'-fluorobenzylidene) -1-n-propylsorbitol, 1,3: 2,4-bis-O- (3'-bromo-4'-ethylbenzylidene)- 1-n-propyl sorbitol, 1,3: 2,4-bis-O- (pn-propylbenzylidene) -1-propenyl sorbitol, 1,3: 2,4-bis-O- (p-ethoxycarbonyl) Benzylidene) -1-propenylsorbitol, 1,3: 2,4-bis-O- (p-propoxycarbonylbenzylidene) -1-propenylsorbitol, 1,3-O- (pn-propylbenzylidene) -2, 4-O- (p-propoxybenzylidene) -1-propenylsorbitol, 1,3-O- (p-propoxybenzylidene) -2,4-O- (pn-propylbenzylidene) -1-propenylsorbitol, 1 , 3: 2,4-bis-O-benzylidene-1-allylsorbitol, 1,3: 2,4-bis-O- (p-methylbenzylidene) -1-allylsorbitol, 1,3: 2,4- Bis-O- (p-ethylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (pn-propylbenzylidene) -1-allylso Rubitol, 1,3: 2,4-bis-O- (2 ', 3'-dimethylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2', 4'-dimethyl Benzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2 ', 5'-dimethylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2 ', 6'-Dimethylbenzylidene) -1-allylsorbitol, 1,3: 2,4-bis-O- (3', 4'-dimethylbenzylidene) -1-allylsorbitol, 1,3: 2,4- Bis-O- (3 ', 5'-dimethylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2', 3'-diethylbenzylidene) -1-allyl sorbitol, 1, 3: 2,4-bis-O- (2 ', 4'-diethylbenzylidene ) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2 ′, 5′-diethylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (2 ′) , 6'-Diethylbenzylidene) -1-allylsorbitol, 1,3: 2,4-bis-O- (3 ', 4'-diethylbenzylidene) -1-allylsorbitol, 1,3: 2,4-bis -O- (p-ethoxycarbonylbenzylidene) -1-allylsorbitol, 1,3: 2,4-bis-O- (p-propoxycarbonylbenzylidene) -1-allylsorbitol, 1,3-O- (p- n-Propylbenzylidene) -2,4-O- (p-propoxybenzylidene) -1-allylsorbitol, 1,3-O- (p-propoxybenzylidene) -2,4-O- (pn-propylbenzylidene) -1-allyl sorbitol, 1,3: 2,4-bis-O- (3 ', 5'-diethylbenzylidene) -1-n-propyl sorbitol, 1,3: 2,4-bis-O- (3 '-Methyl-4'-methoxybenzylidene) -1-allylsorbitol, 1,3: 2,4-bis-O- (3', 4'-dichlorobenzylidene) -1-allylsorbitol, 1,3: 2, 4-bis-O- (p-methoxycarbonylbenzylidene) -1-allylsorbitol, 1,3: 2,4-bis-O- (3'-methyl-4'-fluorobenzylidene) -1-allylsorbitol, 1 , 3: 2,4-bis-O- (3′-bromo-4′-ethylbenzylidene) -1-allylsorbitol and the like.
特に、好ましい態様としては、1,3:2,4−ビス−O−(p−メチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−エチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−プロピルソルビトールなどが例示される。 In a particularly preferred embodiment, 1,3: 2,4-bis-O- (p-methylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -D -Sorbitol, 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (pn-propylbenzylidene) Examples include -1-propyl sorbitol and the like.
また、上記具体的な態様のジアセタール化合物は、単独で用いてもよいが、他の性能、例えば低温加工性等の観点から、2種以上のジアセタール化合物を併用、または予め混合した態様で用いてもよい。 Further, the diacetal compound of the specific embodiment may be used alone, but from the viewpoint of other performances such as low temperature processability, two or more kinds of diacetal compounds are used in combination or are used in a premixed manner. Good.
上記併用または混合系で用いる場合、例えば、1,3:2,4−ジ−O−ベンジリデン−D−ソルビトールと1,3:2,4−ビス−O−(p−メチルベンジリデン)−D−ソルビトールの組合せや1,3:2,4−ビス−O−(p−エチルベンジリデン)−D−ソルビトールと1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトールの組合せ、1,3:2,4−ジベンジリデン−D−ソルビトールと1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトールの組合せ、1,3:2,4−ビス−O−(p−メチルベンジリデン)−D−ソルビトールと1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(p−クロロベンジリデン)−D−ソルビトールと1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、1,3:2,4−ビス−O−(3’,4’−ジクロロベンジリデン)−D−ソルビトールと1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール、の組合せなどが例示され、どちらか一方のみを微粉砕して用いても構わない。 When used in the above combination or mixed system, for example, 1,3: 2,4-di-O-benzylidene-D-sorbitol and 1,3: 2,4-bis-O- (p-methylbenzylidene) -D- A combination of sorbitol, 1,3: 2,4-bis-O- (p-ethylbenzylidene) -D-sorbitol and 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene)- A combination of D-sorbitol, a combination of 1,3: 2,4-dibenzylidene-D-sorbitol and 1,3: 2,4-bis-O- (3 ′, 4′-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p-methylbenzylidene) -D-sorbitol and 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (p- Lolobenzylidene) -D-sorbitol and 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol, 1,3: 2,4-bis-O- (3'. , 4'-dichlorobenzylidene) -D-sorbitol and 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol are exemplified, and only one of them is exemplified. May be finely pulverized before use.
上記ジアセタール化合物は、例えば、日本国特公昭48−43748号公報、特開昭53−5165号公報、特開昭57−185287号公報、特開平2−231488号公報等に記載されている製造方法などを用いて容易に製造することができる。また、現在ポリオレフィン用結晶核剤として市販されているもの、例えば、ミリケン社(米国)のミラッド3988、ミラッドNX8000、新日本理化(株)のゲルオールD、ゲルオールMD、ゲルオールDXRなどをそのまま使用してもよい。 The diacetal compounds are described in, for example, Japanese Patent Publication No. 48-43748, Japanese Patent Laid-Open No. 53-5165, Japanese Patent Laid-Open No. 57-185287, Japanese Patent Laid-Open No. 2-231488, and the like. It can be easily manufactured by using Also, what is currently marketed as a crystal nucleating agent for polyolefins, for example, Millad 3988, Millad NX8000 of Milliken (USA), Gelol D, Gelol MD, Gelol DXR of New Japan Rika Co., Ltd. are used as they are. Good.
また、上記ジアセタール化合物以外の結晶核剤としては、例えば、安息香酸ナトリウム塩、p−t−ブチル安息香酸アルミニウム塩、下記一般式(3)で示されるシクロヘキサンジカルボン酸金属塩、下記一般式(4)で表されるノルボルナンジカルボン酸金属塩などのカルボン酸塩系化合物、下記一般式(5)で示されるリン酸エステル塩系化合物、下記一般式(6)で示されるアミド系化合物、下記一般式(7)で示されるロジン酸又はその金属塩化合物(例えば、リチウム、ナトリウム、カリウム、マグネシウムなどのアルカリ金属塩)等のロジン系化合物などが例示される。
本発明の顆粒状ポリオレフィン系樹脂用結晶核剤又はコアとなる顆粒状ポリオレフィン系樹脂用結晶核剤中に占める(A)成分の割合は、60〜80重量%であり、好ましくは65〜75重量%であることが推奨される。 The ratio of the component (A) in the crystal nucleating agent for granular polyolefin resin of the present invention or the crystal nucleating agent for granular polyolefin resin to be the core is 60 to 80% by weight, and preferably 65 to 75% by weight. % Is recommended.
工程(ii)における(D)成分の配合量は、本発明の顆粒状ポリオレフィン系樹脂用結晶核剤の使用条件により、適宜選択されるものであり、本発明の効果を奏する限り、特に限定されるものではないが、好ましくはコアとなる顆粒状ポリオレフィン系樹脂用結晶核剤100重量部に対して1〜20重量部、より好ましくは5〜15重量部であることが推奨される。(D)成分の配合量が上記範囲であれば、広範囲な使用条件に適応して、ケーキングを解消することができる。 The blending amount of the component (D) in the step (ii) is appropriately selected depending on the use conditions of the crystal nucleating agent for a granular polyolefin resin of the present invention, and is not particularly limited as long as the effects of the present invention are exhibited. Although not limited, it is recommended that the amount is preferably 1 to 20 parts by weight, more preferably 5 to 15 parts by weight, based on 100 parts by weight of the crystal nucleating agent for the granular polyolefin resin serving as the core. When the compounding amount of the component (D) is within the above range, caking can be eliminated by adapting to a wide range of use conditions.
(B)成分:有機酸モノグリセリド
(B)成分である有機酸モノグリセリドとしては、本発明の効果を奏するものであれば、どの様な構造の有機酸モノグリセリドでも使用することができるが、好ましくは、分子内に少なくとも水酸基1個を有していてもよい脂肪酸のモノグリセリドであることが推奨され、より好ましくは前記脂肪酸が炭素数12〜24の飽和脂肪酸であることが特に推奨される。
Component (B): Organic acid monoglyceride As the organic acid monoglyceride which is the component (B), any structure of organic acid monoglyceride can be used as long as it has the effects of the present invention, but preferably, It is recommended to be a monoglyceride of a fatty acid which may have at least one hydroxyl group in the molecule, and it is particularly preferred that the fatty acid is a saturated fatty acid having 12 to 24 carbon atoms.
具体的には、例えば、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ノナデカン酸、アラキジン酸、ベヘン酸、リグノセリン酸などの飽和脂肪酸のモノグリセリドやパルミトレイン酸、オレイン酸、エライジン酸、ガドレイン酸、エルカ酸、ネルボン酸、リノール酸、エイコサジエン酸、ドコサジエン酸、リノレン酸、ステアリドン酸、アラキドン酸、エイコサペンタエン酸、ドコサヘキサエン酸、ウンデシレン酸などの不飽和脂肪酸のモノグリセリド、さらに、イソステアリン酸、リシノレイン酸、12−ヒドロキシステアリン酸、9−ヒドロキシステアリン酸、10−ヒドロキシステアリン酸、水素添加ヒマシ油脂肪酸(12−ヒドロキシステアリン酸の他に少量のステアリン酸及びパルミチン酸を含有する脂肪酸)などの分岐鎖や置換基を有する脂肪酸のグリセリド等が挙げられる。 Specifically, for example, lauric acid, myristic acid, palmitic acid, stearic acid, stearic acid, nonadecanoic acid, arachidic acid, behenic acid, monoglycerides of saturated fatty acids such as lignoceric acid and palmitoleic acid, oleic acid, elaidic acid, gadoleic acid, erucic acid. Monoglycerides of unsaturated fatty acids such as acids, nervonic acid, linoleic acid, eicosadienoic acid, docosadienoic acid, linolenic acid, stearidonic acid, arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, undecylenic acid, and further isostearic acid, ricinoleic acid, 12- Hydroxystearic acid, 9-hydroxystearic acid, 10-hydroxystearic acid, hydrogenated castor oil fatty acid (fatty acid containing a small amount of stearic acid and palmitic acid in addition to 12-hydroxystearic acid), etc. Glycerides of fatty acids or the like having a 岐鎖 or substituents.
上記有機酸モノグリセリドの中でも、特にステアリン酸モノグリセリド、ベヘン酸モノグリセリド、12−ヒドロキステアリン酸モノグリセリドが推奨され、更にステアリン酸モノグリセリドが最も推奨される。 Among the above-mentioned organic acid monoglycerides, stearic acid monoglyceride, behenic acid monoglyceride and 12-hydroxystearic acid monoglyceride are particularly recommended, and stearic acid monoglyceride is most recommended.
(C)成分:100℃以上の融点を有する有機化合物
(C)成分である100℃以上の融点を有する有機化合物としては、本発明の効果を奏するものであれば、100℃以上の融点を有する限りどの様な構造の有機化合物でも使用することができるが、好ましくは、炭素数14〜22の飽和脂肪酸のアルカリ又はアルカリ土類金属塩や遷移金属塩、ヒンダードフェノール系化合物、及び亜リン酸エステル系化合物からなる群より選ばれた1種又は2種以上の化合物であることが特に推奨される。
Component (C): Organic compound having a melting point of 100 ° C. or higher An organic compound having a melting point of 100 ° C. or higher, which is the component (C), has a melting point of 100 ° C. or higher as long as the effects of the present invention are exhibited. Although any organic compound having any structure can be used, preferably, an alkali or alkaline earth metal salt or transition metal salt of a saturated fatty acid having 14 to 22 carbon atoms, a hindered phenol compound, and phosphorous acid. It is particularly recommended that the compound is one or more compounds selected from the group consisting of ester compounds.
具体的には、炭素数14〜22の飽和脂肪酸のアルカリ又はアルカリ土類金属塩としては、例えば、ミリスチン酸、パルミチン酸、ステアリン酸、ノナデカン酸、アラキジン酸、ベヘン酸、リグノセリン酸などの飽和脂肪酸やイソステアリン酸、リシノレイン酸、12−ヒドロキシステアリン酸、9−ヒドロキシステアリン酸、10−ヒドロキシステアリン酸、水素添加ヒマシ油脂肪酸(12−ヒドロキシステアリン酸の他に少量のステアリン酸及びパルミチン酸を含有する脂肪酸)などの分岐鎖や置換基を有する飽和脂肪酸のリチウム、ナトリウム、カリウム、セシウム等のアルカリ金属塩、カルシウム、マグネシウム、バリウム等のアルカリ金属塩、亜鉛等の遷移金属塩等が挙げられる。中でも、ステアリン酸、ベヘン酸、12−ヒドロキシステアリン酸のカルシウム塩、マグネシウム塩、亜鉛塩などが特に好ましい化合物として推奨される。 Specifically, examples of alkali or alkaline earth metal salts of saturated fatty acids having 14 to 22 carbon atoms include saturated fatty acids such as myristic acid, palmitic acid, stearic acid, nonadecanoic acid, arachidic acid, behenic acid, and lignoceric acid. And isostearic acid, ricinoleic acid, 12-hydroxystearic acid, 9-hydroxystearic acid, 10-hydroxystearic acid, hydrogenated castor oil fatty acid (fatty acid containing a small amount of stearic acid and palmitic acid in addition to 12-hydroxystearic acid ) And the like, saturated metal salts of saturated fatty acids having a branched chain or a substituent such as lithium, sodium, potassium and cesium, alkali metal salts such as calcium, magnesium and barium, and transition metal salts such as zinc. Among them, stearic acid, behenic acid, 12-hydroxystearic acid calcium salt, magnesium salt, zinc salt and the like are recommended as particularly preferable compounds.
具体的には、ヒンダードフェノール系化合物としては、例えば、2,6−ジフェニル−4−オクタデシロキシフェノール、4,4’−メチレンビス(2,6−ジ−t−ブチルフェノール)、2−[1−(2−ヒドロキシ−3,5−ジ−t−ペンチルフェニル)エチル]−4,6−ジ−t−ペンチルフェニルアクリレート、トリエチレングリコール−ビス[3−(3−t−ブチル−5−メチル−4−ヒドロキシフェニル)プロピオネート]、1,6−ヘキサンジオール−ビス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]、3,9−ビス[2−[3−(3−t−ブチル−5−メチル−4−ヒドロキシフェニル)−プロピオニルオキシ]−1,1−ジメチルエチル]−2,4,8,10−テトラオキサスピロ[5・5]ウンデカン、1,1,3−トリス(2−メチル−5−t−ブチル−4−ヒドロキシフェニル)ブタン、2,4,6−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)メシチレン、テトラキス−[メチレン−3−(3’,5’−ジ−t−ブチル−4’−ヒドロキシフェニル)プロピオネート]メタン、ビス[3,3−ビス−(3’−t−ブチル−4’−ヒドロキシフェニル)ブチリックアシッド]エチレングリコールエステル、2,6−ビス(2−ヒドロキシ−3−t−ブチル−5−メチルベンジル)−4−メチルフェノール、ビス[2−t−ブチル−4−メチル−6−(2−ヒドロキシ−3−t−ブチル−5−メチルベンジル)フェニル]テレフタレート、α−トコフェロール、β−トコフェロール、γ−トコフェロール、α‐トコトリエノール、β−トコトリエノール、γ−トコトリエノール、没食子酸ドデシル、没食子酸ヘキサデシル、没食子酸ステアリル、3−(4−ヒドロキシ−3,5−ジイソプロピルフェニル)プロピオン酸オクチル、2,4−ジメチル−6−(1−メチルペンタデシル)−フェノール、2,2’−メチレンビス(4−メチル−6−t−ブチルフェノール)、2,2’−メチレンビス(4−エチル−6−t−ブチルフェノール)、4,4’−ブチリデンビス(3−メチル−6−t−ブチルフェノール)、ノルジヒドログアイアレチン酸、2,2’−メチレンビス[4−メチル−6−ノニルフェノール]、2,2’−メチレンビス[6−(1−メチルシクロヘキシル)−4−メチルフェノール]、2,2’−[(2−ヒドロキシ−5−メチルベンゼン−1,3−ジイル)ジメタンジイル]ビス(4−メチル−6−ノニルフェノール)、2,2’−チオジエチルビス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]、4,4’−チオビス(2−t−ブチル−5−メチルフェノール)、2−ヒドロキシ−4−n−オクチルオキシベンゾフェノン、2−(2’−ヒドロキシ−3’−t−ブチル−5’−メチルフェニル)5−クロロベンゾトリアゾール、2−t−ブチル−6−(3−t−ブチル−2−ヒドロキシ−5−メチルベンジル)−4−メチルフェニルアクリレート、N,N’−(1,6−ヘキサンジイル)ビス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオンアミド]、1,3,5−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)イソシアヌレート、1,3,5−トリス(4−t−ブチル−3−ヒドロキシ−2,6−ジメチルベンジル)イソシアヌレート、2,2’−エチリデンビス(4,6−ジ−t−ブチルフェノール)、2,2’−エチリデンビス(4−s−ブチル−6−t−ブチルフェノール)、1,3,5−トリス[(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオニルオキシエチル]イソシアヌレート、クルクミンなどの化合物が例示される。 Specifically, examples of the hindered phenol compound include 2,6-diphenyl-4-octadecyloxyphenol, 4,4′-methylenebis (2,6-di-t-butylphenol), 2- [1 -(2-Hydroxy-3,5-di-t-pentylphenyl) ethyl] -4,6-di-t-pentylphenyl acrylate, triethylene glycol-bis [3- (3-t-butyl-5-methyl) -4-hydroxyphenyl) propionate], 1,6-hexanediol-bis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate], 3,9-bis [2- [3- (3-t-Butyl-5-methyl-4-hydroxyphenyl) -propionyloxy] -1,1-dimethylethyl] -2,4,8,10-tetraoxaspiro [5 5] Undecane, 1,1,3-tris (2-methyl-5-t-butyl-4-hydroxyphenyl) butane, 2,4,6-tris (3,5-di-t-butyl-4-hydroxy) Benzyl) mesitylene, tetrakis- [methylene-3- (3 ', 5'-di-t-butyl-4'-hydroxyphenyl) propionate] methane, bis [3,3-bis- (3'-t-butyl- 4'-hydroxyphenyl) butyric acid] ethylene glycol ester, 2,6-bis (2-hydroxy-3-t-butyl-5-methylbenzyl) -4-methylphenol, bis [2-t-butyl-4] -Methyl-6- (2-hydroxy-3-t-butyl-5-methylbenzyl) phenyl] terephthalate, α-tocopherol, β-tocopherol, γ-tocopherol, α- Cotrienol, β-tocotrienol, γ-tocotrienol, dodecyl gallate, hexadecyl gallate, stearyl gallate, octyl 3- (4-hydroxy-3,5-diisopropylphenyl) propionate, 2,4-dimethyl-6- ( 1-methylpentadecyl) -phenol, 2,2'-methylenebis (4-methyl-6-t-butylphenol), 2,2'-methylenebis (4-ethyl-6-t-butylphenol), 4,4'- Butylidene bis (3-methyl-6-t-butylphenol), nordihydroguaiaretic acid, 2,2'-methylenebis [4-methyl-6-nonylphenol], 2,2'-methylenebis [6- (1-methylcyclohexyl) ) -4-Methylphenol], 2,2 ′-[(2-hydroxy-5-methylbenzene-1, -Diyl) dimethanediyl] bis (4-methyl-6-nonylphenol), 2,2'-thiodiethylbis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate], 4,4 ' -Thiobis (2-t-butyl-5-methylphenol), 2-hydroxy-4-n-octyloxybenzophenone, 2- (2'-hydroxy-3'-t-butyl-5'-methylphenyl) 5- Chlorobenzotriazole, 2-t-butyl-6- (3-t-butyl-2-hydroxy-5-methylbenzyl) -4-methylphenyl acrylate, N, N '-(1,6-hexanediyl) bis [ 3- (3,5-di-t-butyl-4-hydroxyphenyl) propionamide], 1,3,5-tris (3,5-di-t-butyl-4-hydroxybenzyl) isocyanurate, 1, Three , 5-Tris (4-t-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate, 2,2'-ethylidene bis (4,6-di-t-butylphenol), 2,2'-ethylidene Compounds such as bis (4-s-butyl-6-t-butylphenol), 1,3,5-tris [(3,5-di-t-butyl-4-hydroxyphenyl) propionyloxyethyl] isocyanurate, curcumin Is exemplified.
上記化合物の中でも、4,4’−メチレンビス(2,6−ジ−t−ブチルフェノール)、3,9−ビス[2−[3−(3−t−ブチル−5−メチル−4−ヒドロキシフェニル)−プロピオニルオキシ]−1,1−ジメチルエチル]−2,4,8,10−テトラオキサスピロ[5・5]ウンデカン、1,1,3−トリス(2−メチル−5−t−ブチル−4−ヒドロキシフェニル)ブタン、2,4,6−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)メシチレン、テトラキス−[メチレン−3−(3’,5’−ジ−t−ブチル−4’−ヒドロキシフェニル)プロピオネート]メタン、2,2’−チオジエチルビス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]、N,N’−(1,6−ヘキサンジイル)ビス[3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオンアミド]、1,3,5−トリス(3,5−ジ−t−ブチル−4−ヒドロキシベンジル)イソシアヌレートなどの化合物が推奨され、その中でも、3,9−ビス[2−[3−(3−t−ブチル−5−メチル−4−ヒドロキシフェニル)−プロピオニルオキシ]−1,1−ジメチルエチル]−2,4,8,10−テトラオキサスピロ[5・5]ウンデカン、1,1,3−トリス(2−メチル−5−t−ブチル−4−ヒドロキシフェニル)ブタン、テトラキス−[メチレン−3−(3’,5’−ジ−t−ブチル−4’−ヒドロキシフェニル)プロピオネート]メタン、2,6−ビス(2−ヒドロキシ−3−t−ブチル−5−メチルベンジル)−4−メチルフェノール、1,3,5−トリス(4−t−ブチル−3−ヒドロキシ−2,6−ジメチルベンジル)イソシアヌレートなどの化合物が特に推奨され、更にテトラキス−[メチレン−3−(3’,5’−ジ−t−ブチル−4’−ヒドロキシフェニル)プロピオネート]メタンが最も推奨される。 Among the above compounds, 4,4′-methylenebis (2,6-di-t-butylphenol), 3,9-bis [2- [3- (3-t-butyl-5-methyl-4-hydroxyphenyl)) -Propionyloxy] -1,1-dimethylethyl] -2,4,8,10-tetraoxaspiro [5.5] undecane, 1,1,3-tris (2-methyl-5-t-butyl-4) -Hydroxyphenyl) butane, 2,4,6-tris (3,5-di-t-butyl-4-hydroxybenzyl) mesitylene, tetrakis- [methylene-3- (3 ', 5'-di-t-butyl) -4'-Hydroxyphenyl) propionate] methane, 2,2'-thiodiethylbis [3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate], N, N '-(1,6 -Hexanediyl) bis [3 (3,5-di-t-butyl-4-hydroxyphenyl) propionamide], 1,3,5-tris (3,5-di-t-butyl-4-hydroxybenzyl) isocyanurate and other compounds are recommended Among them, 3,9-bis [2- [3- (3-t-butyl-5-methyl-4-hydroxyphenyl) -propionyloxy] -1,1-dimethylethyl] -2,4,8 , 10-Tetraoxaspiro [5.5] undecane, 1,1,3-tris (2-methyl-5-t-butyl-4-hydroxyphenyl) butane, tetrakis- [methylene-3- (3 ′, 5) '-Di-t-butyl-4'-hydroxyphenyl) propionate] methane, 2,6-bis (2-hydroxy-3-t-butyl-5-methylbenzyl) -4-methylphenol, 1,3,5 -Tris Compounds such as (4-t-butyl-3-hydroxy-2,6-dimethylbenzyl) isocyanurate are especially recommended, and further tetrakis- [methylene-3- (3 ', 5'-di-t-butyl-4). '-Hydroxyphenyl) propionate] methane is most recommended.
亜リン酸エステル系化合物としては、例えば、トリフェニルホスファイト、トリスノニルフェニルホスファイト、トリクレジルホスファイト、トリエチルホスファイト、トリス(2−エチルヘキシル)ホスファイト、トリデシルホスファイト、トリラウリルホスファイト、トリス(トリデシル)ホスファイト、トリオレイルホスファイト、ジフェニルモノ(2−エチルヘキシル)ホスファイト、ジフェニルモノデシルホスファイト、ジフェニルモノ(トリデシル)ホスファイト、トリラウリルトリチオホスファイト、テトラフェニルジプロピレングリコールジホスファイト、テトラフェニル(テトラトリデシル)ペンタエリスリトールテトラホスファイトとフタル酸ビス(2−エチルヘキシル)混合物、テトラ(C12〜C15アルキル)−4,4‘−イソプロピリデンジフェニルジホスファイト、ビス(トリデシル)ペンタエリスリトールジホスファイトとビス(ノニルフェニル)ペンタエリスリトールジホスファイトの混合物、ビス(デシル)ペンタエリスリトールジホスファイト、ビス(トリデシル)ペンタエリスリトールジホスファイト、トリステアリルホスファイト、ジステアリルペンタエリスリトールジホスファイト、トリス(2,4−ジ−t−ブチルフェニル)ホスファイト、水添ビスフェノールA・ペンタエリスリトールホスファイトポリマー、水添ビスフェノールAホスファイトポリマーなどが挙げられる。その中でも、トリス(2,4−ジ−t−ブチルフェニル)ホスファイトが特に推奨される。 Examples of the phosphite compound include triphenylphosphite, trisnonylphenylphosphite, tricresylphosphite, triethylphosphite, tris (2-ethylhexyl) phosphite, tridecylphosphite, trilaurylphosphite. , Tris (tridecyl) phosphite, trioleylphosphite, diphenylmono (2-ethylhexyl) phosphite, diphenylmonodecylphosphite, diphenylmono (tridecyl) phosphite, trilauryltrithiophosphite, tetraphenyldipropyleneglycoldiphosphite Fight, a mixture of tetraphenyl (tetratridecyl) pentaerythritol tetraphosphite and bis (2-ethylhexyl) phthalate, tetra (C12-C15 alkyl)- , 4'-isopropylidenediphenyldiphosphite, a mixture of bis (tridecyl) pentaerythritol diphosphite and bis (nonylphenyl) pentaerythritol diphosphite, bis (decyl) pentaerythritol diphosphite, bis (tridecyl) pentaerythritol Diphosphite, tristearyl phosphite, distearyl pentaerythritol diphosphite, tris (2,4-di-t-butylphenyl) phosphite, hydrogenated bisphenol A / pentaerythritol phosphite polymer, hydrogenated bisphenol A phosphite Examples thereof include polymers. Among them, tris (2,4-di-t-butylphenyl) phosphite is particularly recommended.
本発明の顆粒状ポリオレフィン系樹脂用結晶核剤又はコアとなる顆粒状ポリオレフィン系樹脂用結晶核剤中に占める(B)成分の割合は、10〜30重量%であり、好ましくは13〜25重量%であることが推奨される。同様に、(B)成分と(C)成分の合計の割合は、20〜40重量%であり、好ましくは25〜35重量%であることが推奨される。(B)成分の割合が10重量%未満または(B)成分と(C)成分の合計の割合が20重量%未満では、顆粒化が不十分となり、十分な流動性の改良が達成できない懸念がある。 The proportion of the component (B) in the crystal nucleating agent for granular polyolefin-based resin of the present invention or the crystal nucleating agent for granular polyolefin-based resin to be the core is 10 to 30% by weight, preferably 13 to 25% by weight. % Is recommended. Similarly, it is recommended that the total ratio of the components (B) and (C) is 20 to 40% by weight, preferably 25 to 35% by weight. If the ratio of the component (B) is less than 10% by weight or the total ratio of the components (B) and (C) is less than 20% by weight, granulation may be insufficient and sufficient improvement of fluidity may not be achieved. is there.
また、(B)成分の割合が30重量%を超えるとケーキングの懸念が増大し、(B)成分と(C)成分の合計の割合が40重量%を超えると、ポリオレフィン系樹脂用結晶核剤としての性能上問題が生じる懸念があり、いずれも好ましくない。 Further, if the proportion of the component (B) exceeds 30% by weight, the risk of caking increases, and if the proportion of the total of the components (B) and (C) exceeds 40% by weight, a crystal nucleating agent for a polyolefin resin. There is a concern that performance problems may occur, and neither is preferable.
顆粒状ポリオレフィン系樹脂用結晶核剤の製造
本発明の顆粒状ポリオレフィン系樹脂用結晶核剤の製造方法に関して、以下に更に具体的な例を示して、詳しく説明する。但し、本発明は、目的の性能が得られる限り、必ずしも以下の方法に限定されるものではない。
工程(i):(A)ポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド、及び(C)100℃以上の融点を有する有機化合物を、粉体温度を(B)成分の融点以上、(C)成分の融点以下の温度範囲に制御しながら、攪拌造粒する。
Production of Crystal Nucleating Agent for Granular Polyolefin Resin The production method of the crystal nucleating agent for granular polyolefin resin of the present invention will be described in detail below with reference to more specific examples. However, the present invention is not necessarily limited to the following method as long as the desired performance is obtained.
Step (i): (A) a crystal nucleating agent for polyolefin resin, (B) an organic acid monoglyceride, and (C) an organic compound having a melting point of 100 ° C. or higher, a powder temperature of the melting point of the component (B) or higher, Granulation with stirring is performed while controlling the temperature within the melting point of the component (C).
工程(ii):工程(i)で得られた顆粒状ポリオレフィン系樹脂用結晶核剤(コア)に、更に(D)ポリオレフィン系樹脂用結晶核剤を加えて、粉体温度を(B)成分の融点以上、前記工程(i)の粉体温度未満の温度範囲に制御しながら、加熱混合する。 Step (ii): (D) A crystal nucleating agent for polyolefin resin is added to the crystal nucleating agent for core polyolefin resin (core) obtained in step (i) to adjust the powder temperature to the component (B). The mixture is heated and mixed while being controlled in a temperature range not lower than the melting point of the above and less than the powder temperature of the step (i).
上記工程(i)における攪拌造粒は、撹拌しながら造粒することができればよく、汎用の攪拌槽内部に攪拌翼を有する加熱可能な攪拌造粒機を使うことができる。代表的な攪拌造粒機としては、例えば、攪拌転動造粒機(ハイスピードミキサーなど)、高速攪拌造粒機(ヘンシェルミキサーなど)、バーティカルグラニュレーター、ファーママトリックス、スーパーミキサー、GRAL−グラル、シュギミキサー、ハイスピーダー、ニュースピードニーダ等の竪型ミキサーや、レディゲミキサー、スパルタンリューザー、ピンミキサー等の横型ミキサー等を例示され、その中でも、攪拌転動造粒機や高速攪拌造粒機などが特に推奨される。 The agitation granulation in the step (i) may be performed as long as granulation can be performed while stirring, and a heatable agitation granulator having a stirring blade inside a general-purpose stirring tank can be used. Typical agitation granulators include, for example, agitation tumbling granulators (high-speed mixers, etc.), high-speed agitation granulators (Henschel mixers, etc.), vertical granulators, pharmaceutical matrices, super mixers, GRAL-grall, Vertical mixers such as Shugi mixer, high speeder, new speed kneader, etc., horizontal mixers such as Loedige mixer, Spartan Luzer, pin mixer, etc. are exemplified. Among them, stirring rolling granulator and high speed stirring granulator Are especially recommended.
上記工程(ii)における加熱混合は、加熱下で混合することができればよく、万能混合機などの汎用の攪拌混合機を用いることもできるが、生産性を考慮すると、上記工程(i)で使用した攪拌造粒機をそのまま用いる方法が効率的であり、好ましい。 The heating and mixing in the step (ii) may be performed as long as it can be mixed under heating, and a general-purpose stirring mixer such as a universal mixer can be used, but in view of productivity, it is used in the step (i). The method using the stirring granulator as it is is efficient and preferable.
上記工程(i)における、各成分の仕込み方法は、特に限定されないが、例えば3成分を同時に仕込んだ後に加熱下で攪拌造粒する方法や、予め(A)成分のみを仕込んで加熱下で攪拌している中に、残りの(B)成分及び(C)成分を一括して若しくは逐次的に投入して、撹拌造粒する方法などが挙げられる。 The method of charging each component in the above step (i) is not particularly limited. For example, a method of simultaneously charging three components and then stirring and granulating under heating, or a method of charging only component (A) in advance and stirring under heating. In the meantime, a method of adding the remaining components (B) and (C) all at once or sequentially and performing granulation with stirring can be mentioned.
本発明の特許請求の範囲及び明細書における「粉体温度」とは、攪拌造粒や攪拌混合、加熱混合時の粉末又は顆粒状の混合物である粉体の実温度を意味し、例えば、その攪拌造粒や攪拌混合、加熱混合に用いる装置内に温度計を設置又は挿入することにより容易に測定することができる。 The "powder temperature" in the claims and the specification of the present invention means the actual temperature of powder which is a powder or a granular mixture at the time of stirring granulation, stirring and mixing, and heating mixing, for example, It can be easily measured by installing or inserting a thermometer in an apparatus used for stirring granulation, stirring mixing, and heating mixing.
粉体温度の制御は、例えば、攪拌装置が有する加熱手段、具体的には、攪拌装置のジャケット等に熱媒を通して加熱昇温後、装置内に設置した温度計にて実際の粉体温度を測定しながら、上記熱媒による加熱又は剪断発熱による加熱、更に剪断発熱が大きい場合は冷媒による冷却を調整することにより、粉体温度を制御する方法などを挙げることができる。 The powder temperature can be controlled, for example, by heating the heating means of the stirrer, specifically, by heating a heating medium through a jacket of the stirrer to raise the temperature, and then measuring the actual powder temperature with a thermometer installed in the apparatus. Examples of the method include controlling the powder temperature by adjusting the heating by the heat medium or the heating by shearing heat while measuring, or by adjusting the cooling by the refrigerant when the heating by shearing is large.
本発明に係る粉体温度の制御範囲は、(B)成分及び(C)成分の種類に依存するものであり、具体的には、工程(i)の粉体温度は、好ましくは(B)成分の融点以上、(C)成分の融点以下の範囲であり、特に好ましくは(B)成分の融点+10℃〜(C)成分の融点−10℃の間の温度範囲であることが推奨される。また、工程(ii)の粉体温度は、好ましくは(B)成分の融点〜(B)成分の融点+50℃の範囲であり、且つ工程(i)の加熱温度未満であることが推奨される。 The control range of the powder temperature according to the present invention depends on the types of the component (B) and the component (C), and specifically, the powder temperature in the step (i) is preferably (B). It is recommended that the temperature range is not lower than the melting point of the component and not higher than the melting point of the component (C), and particularly preferably a temperature range between the melting point of the component (B) + 10 ° C. and the melting point of the component (C) −10 ° C. . The powder temperature in step (ii) is preferably in the range of the melting point of component (B) to the melting point of component (B) + 50 ° C., and is recommended to be lower than the heating temperature of step (i). .
<ポリオレフィン系樹脂組成物>
本発明のポリオレフィン系樹脂組成物は、本発明に係る上記ポリオレフィン系樹脂用結晶核剤とポリオレフィン系樹脂とを、必要に応じてその他のポリオレフィン系樹脂用添加剤を加えて、室温にてドライブレンド後、所定の条件にて溶融混合することにより、容易に得ることができる。
<Polyolefin resin composition>
The polyolefin resin composition of the present invention is a crystal nucleating agent for a polyolefin resin according to the present invention and a polyolefin resin, and optionally other polyolefin resin additives are added, and dry blended at room temperature. Then, it can be easily obtained by melt mixing under predetermined conditions.
ポリオレフィン系樹脂中の本発明に係るポリオレフィン系樹脂用結晶核剤の濃度は、本発明に係るポリオレフィン系樹脂用結晶核剤としての効果を奏する限り、特に制約はないが、ポリオレフィン系樹脂100重量部に対して、好ましくは0.001〜10重量部、より好ましくは0.01〜5重量部であることが好ましい。 The concentration of the polyolefin-based resin crystal nucleating agent according to the present invention in the polyolefin-based resin is not particularly limited as long as the effect as the polyolefin-based resin crystal nucleating agent according to the present invention is exhibited, but the polyolefin-based resin 100 parts by weight. On the other hand, it is preferably 0.001 to 10 parts by weight, more preferably 0.01 to 5 parts by weight.
[ポリオレフィン系樹脂]
上記ポリオレフィン系樹脂としては、本発明の効果を奏する限り特に限定されることなく、従来公知のポリオレフィン系樹脂が使用可能であり、例えば、ポリエチレン系樹脂、ポリプロピレン系樹脂、ポリブテン系樹脂、ポリメチルペンテン系樹脂、ポリブタジエン系樹脂などが例示される。より具体的には、高密度ポリエチレン、中密度ポリエチレン、直鎖状ポリエチレン、エチレン含量50重量%以上、好ましくは70重量%以上のエチレンコポリマー、プロピレンホモポリマー、プロピレン50重量%以上、好ましくは70重量%以上のプロピレンコポリマー、ブテンホモポリマー、ブテン含量50重量%以上、好ましくは70重量%以上のブテンコポリマー、メチルペンテンホモポリマー、メチルペンテン含量50重量%以上、好ましくは70重量%以上のメチルペンテンコポリマー、ポリブタジエン等が例示される。また、上記コポリマーはランダムコポリマーであってもよく、ブロックコポリマーであってもよい。更に、これらの樹脂の立体規則性がある場合は、アイソタクチックでもシンジオタクチックでもよい。上記コポリマーを構成し得るコモノマーとして、具体的にはエチレン、プロピレン、ブテン、ペンテン、ヘキセン、ヘプテン、オクテン、ノネン、デセン、ウンデセン、ドデセン等の炭素数2〜12のα−オレフィン、1,4−エンドメチレンシクロヘキセン等のビシクロ型モノマー、(メタ)アクリル酸メチル、(メタ)アクリル酸エチル等の(メタ)アクリル酸エステル、酢酸ビニル等が例示される。
[Polyolefin resin]
The polyolefin-based resin is not particularly limited as long as the effects of the present invention are exhibited, and conventionally known polyolefin-based resins can be used. For example, polyethylene-based resin, polypropylene-based resin, polybutene-based resin, polymethylpentene Examples thereof include resin based resins and polybutadiene based resins. More specifically, high density polyethylene, medium density polyethylene, linear polyethylene, ethylene content 50% by weight or more, preferably 70% by weight or more ethylene copolymer, propylene homopolymer, propylene 50% by weight or more, preferably 70% by weight. % Or more propylene copolymer, butene homopolymer, butene content 50% by weight or more, preferably 70% by weight or more butene copolymer, methylpentene homopolymer, methylpentene content 50% by weight or more, preferably 70% by weight or more methylpentene copolymer , Polybutadiene, etc. are exemplified. The above copolymer may be a random copolymer or a block copolymer. Further, when these resins have stereoregularity, they may be isotactic or syndiotactic. Specific examples of the comonomer that can form the copolymer include ethylene, propylene, butene, pentene, hexene, heptene, octene, nonene, decene, undecene, and dodecene. Examples thereof include bicyclo type monomers such as endomethylene cyclohexene, methyl (meth) acrylate, (meth) acrylates such as ethyl (meth) acrylate, vinyl acetate and the like.
かかる重合体を製造するために適用される触媒としては、一般に使用されているチーグラー・ナッタ型触媒はもちろん、遷移金属化合物(例えば、三塩化チタン、四塩化チタン等のチタンのハロゲン化物)を塩化マグネシウム等のハロゲン化マグネシウムを主成分とする担体に担持してなる触媒と、アルキルアルミニウム化合物(トリエチルアルミニウム、ジエチルアルミニウムクロリド等)とを組み合わせてなる触媒系、メタロセン触媒等も使用できる。 As a catalyst applied for producing such a polymer, not only a commonly used Ziegler-Natta type catalyst but also a transition metal compound (for example, titanium halide such as titanium trichloride or titanium tetrachloride) is chlorinated. A catalyst system in which a catalyst supported on a carrier containing magnesium halide such as magnesium as a main component and an alkylaluminum compound (triethylaluminum, diethylaluminum chloride, etc.) are combined, a metallocene catalyst and the like can also be used.
本発明に係るポリオレフィン系樹脂のメルトフローレート(以下「MFR」と略記する。JIS K 7210−1999)は、その適用する成形方法により適宜選択されるが、通常0.01〜200g/10分程度、好ましくは0.05〜100g/10分程度が推奨される。 The melt flow rate (hereinafter abbreviated as "MFR". JIS K 7210-1999) of the polyolefin resin according to the present invention is appropriately selected depending on the molding method applied, but is usually about 0.01 to 200 g / 10 minutes. , Preferably about 0.05 to 100 g / 10 minutes is recommended.
[その他の添加剤]
また、上述の通り、本発明のポリオレフィン系樹脂組成物には、その使用目的やその用途に応じて、本発明の効果を損なわない範囲でその他のポリオレフィン系樹脂用添加剤が含まれていてもよい。
[Other additives]
Further, as described above, the polyolefin-based resin composition of the present invention may contain other additives for polyolefin-based resin in a range that does not impair the effects of the present invention, depending on the purpose of use and the use thereof. Good.
上記ポリオレフィン系樹脂用添加剤としては、例えば、ポリオレフィン等衛生協議会編「ポジティブリストの添加剤要覧」(2002年1月)に記載されている各種添加剤が挙げられる。具体的には、蛍光増白剤(2,5−チオフェンジイル(5−t−ブチル−1,3−ベンゾキサゾール)、4,4’−ビス(ベンゾオキサゾール−2−イル)スチルベン等)、酸化防止剤、安定剤(金属化合物、エポキシ化合物、窒素化合物、燐化合物、硫黄化合物等)、紫外線吸収剤(ベンゾフェノン系化合物、ベンゾトリアゾール系化合物等)、界面活性剤、滑剤(パラフィン、ワックス等の脂肪族炭化水素、炭素数8〜22の高級脂肪酸、炭素数8〜22の高級脂肪酸金属(Al、Ca)塩、炭素数8〜22の高級脂肪族アルコール、ポリグリコール、炭素数4〜22の高級脂肪酸と炭素数4〜18の脂肪族1価アルコールとのエステル、炭素数8〜22の高級脂肪酸アマイド、シリコーン油、ロジン誘導体等)、充填剤(タルク、ハイドロタルサイト、マイカ、ゼオライト、パーライト、珪藻土、炭酸カルシウム、ガラス繊維等)、発泡剤、発泡助剤、ポリマー添加剤、可塑剤(ジアルキルフタレート、ジアルキルヘキサヒドロフタレート等)、架橋剤、架橋促進剤、帯電防止剤、難燃剤、分散剤、有機無機の顔料(インディゴ化合物、フタロシアニン系化合物、アントラキノン系化合物、ウルトラマリン化合物、アルミン酸コバルト化合物等)、加工助剤、他の核剤等の各種添加剤が例示される。 Examples of the above-mentioned additives for polyolefin resins include various additives described in "Positive List Additives Manual" (January 2002) edited by the Hygiene Council for Polyolefins. Specifically, optical brighteners (2,5-thiophenediyl (5-t-butyl-1,3-benzoxazole), 4,4′-bis (benzoxazol-2-yl) stilbene, etc.), Antioxidants, stabilizers (metal compounds, epoxy compounds, nitrogen compounds, phosphorus compounds, sulfur compounds, etc.), ultraviolet absorbers (benzophenone compounds, benzotriazole compounds, etc.), surfactants, lubricants (paraffins, waxes, etc.) Aliphatic hydrocarbon, higher fatty acid having 8 to 22 carbon atoms, higher fatty acid metal (Al, Ca) salt having 8 to 22 carbon atoms, higher aliphatic alcohol having 8 to 22 carbon atoms, polyglycol, having 4 to 22 carbon atoms Ester of higher fatty acid and aliphatic monohydric alcohol having 4 to 18 carbon atoms, higher fatty acid amide having 8 to 22 carbon atoms, silicone oil, rosin derivative, etc., filler (talc, high Rotalsite, mica, zeolite, perlite, diatomaceous earth, calcium carbonate, glass fiber, etc.), foaming agent, foaming aid, polymer additive, plasticizer (dialkyl phthalate, dialkyl hexahydrophthalate, etc.), cross-linking agent, cross-linking accelerator, charging Various additives such as inhibitors, flame retardants, dispersants, organic and inorganic pigments (indigo compounds, phthalocyanine compounds, anthraquinone compounds, ultramarine compounds, cobalt aluminate compounds, etc.), processing aids, other nucleating agents, etc. It is illustrated.
これらの添加剤を使用する場合、その使用量は、本発明の効果を阻害しない限り、通常使用されている範囲で使用すればよいが、例えば、ポリオレフィン系樹脂100重量部に対して、好ましくは0.0001〜100重量部程度、より好ましくは0.001〜50重量部程度で使用されるのが一般的である。 When these additives are used, the amount thereof may be used within a range usually used unless the effects of the present invention are impaired. For example, it is preferable to use 100 parts by weight of the polyolefin resin. It is generally used in an amount of about 0.0001 to 100 parts by weight, more preferably about 0.001 to 50 parts by weight.
上記酸化防止剤としては、上述のフェノール化合物や亜リン酸エステル系化合物に加えてフェノール系酸化防止剤、亜リン酸エステル系酸化防止剤を加えてもよく、さらにイオウ系酸化防止剤を加えることもできる。具体的な酸化防止剤としては、2,6−ジ−t−ブチルフェノール、テトラキス[メチレン−3−(3,5−t−ブチル−4−ヒドロキシフェノール)プロピオネート]メタン、2−ヒドロキシ−4−メトキシベンゾフェノンなどのフェノール系酸化防止剤、アルキルジスルフィド、チオジプロピオン酸エステル、ベンゾチアゾールなどの硫黄系酸化防止剤、トリスノニルフェニルホスファイト、ジフェニルイソデシルホスファイト、トリフェニルホスファイト、トリス(2,4−ジ−t−ブチルフェニル)ホスファイト、3,9−ビス(2,6−t−ブチル−4−メチルフェノキシ)−2,4,8,10−テトラオキサ−3,9−ジホスファスピロ[5,5]ウンデカンなどの亜リン酸エステル系酸化防止剤等が例示される。中でも、フェノール系酸化防止剤であるテトラキス[メチレン−3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]メタン、亜リン酸エステル系の酸化防止剤であるトリス(2,4−ジ−t−ブチルフェニル)ホスファイト、3,9−ビス(2,6−t−ブチル−4−メチルフェノキシ)−2,4,8,10−テトラオキサ−3,9−ジホスファスピロ[5,5]ウンデカンなどが特に推奨される。 As the above-mentioned antioxidant, in addition to the above-mentioned phenol compound or phosphite ester-based compound, a phenol-based antioxidant, a phosphite-based antioxidant may be added, and further a sulfur-based antioxidant should be added. You can also Specific antioxidants include 2,6-di-t-butylphenol, tetrakis [methylene-3- (3,5-t-butyl-4-hydroxyphenol) propionate] methane, 2-hydroxy-4-methoxy. Phenolic antioxidants such as benzophenone, alkyl disulfides, thiodipropionates, sulfur antioxidants such as benzothiazole, trisnonylphenyl phosphite, diphenylisodecyl phosphite, triphenyl phosphite, tris (2,4 -Di-t-butylphenyl) phosphite, 3,9-bis (2,6-t-butyl-4-methylphenoxy) -2,4,8,10-tetraoxa-3,9-diphosphaspiro [5,5 ] Examples include phosphite-based antioxidants such as undecane. Among them, tetrakis [methylene-3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate] methane, which is a phenolic antioxidant, and tris (2,2, which is a phosphite-based antioxidant. 4-di-t-butylphenyl) phosphite, 3,9-bis (2,6-t-butyl-4-methylphenoxy) -2,4,8,10-tetraoxa-3,9-diphosphaspiro [5. 5] Undecane is especially recommended.
<ポリオレフィン系樹脂成形体>
本発明のポリオレフィン系樹脂成形体は、上記本発明のポリオレフィン系樹脂組成物を用いて、慣用されている成形方法に従って成形することにより得られる。前記成形方法としては、本発明の効果を奏する限り、特に制約はなく、射出成形、押出成形、ブロー成形、圧空成形、回転成形、フィルム成形等の従来公知の成形方法のいずれも採用できる。
<Polyolefin resin molding>
The polyolefin-based resin molded product of the present invention can be obtained by molding the above-mentioned polyolefin-based resin composition of the present invention according to a commonly used molding method. The molding method is not particularly limited as long as the effects of the present invention are exhibited, and any conventionally known molding method such as injection molding, extrusion molding, blow molding, pressure molding, rotational molding, film molding, etc. can be adopted.
かくして得られたポリオレフィン系樹脂成形体は、透明性等の光学的特性や耐衝撃性等の機械的特性に優れており、成形品やシート、フィルムとして、自動車部材、電気部材、機械部品、日常雑貨など様々な用途で、非常に有用である。 The polyolefin resin molded product thus obtained has excellent optical properties such as transparency and mechanical properties such as impact resistance, and is used as molded products, sheets and films for automobile parts, electrical parts, mechanical parts, daily life It is very useful for various purposes such as sundries.
以下に実施例を示し、本発明を更に詳しく説明するが、本発明はこれらの実施例によって制限されるものではない。尚、実施例や応用例中の化合物の略号、及び各特性の測定は以下の通りである。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited to these Examples. The abbreviations of the compounds in the examples and application examples and the measurement of each property are as follows.
[結晶核剤の性状]
(1)原料結晶核剤の平均粒径の測定(レーザー回折式粒度分布測定)
レーザー回折式粒度分布計(マルバーンインスツルメンツ社製、「マスターサイザー3000」)を用いて、以下の方法により測定した。まず、湿式測定セルを用い、十分に撹拌混合することで、分散剤としてノニオン系界面活性剤を加えた水溶液中に、試料を分散させ、続いて、得られた混合物を装置内で更に撹拌、循環させながら、超音波を当てて装置内にて十分に均一に分散させた。その後、超音波を当てながら試料の粒度分布を測定した。得られた粒度分布より、体積基準累積50%粒径(d50)を求め、平均粒径とした。
[Properties of crystal nucleating agent]
(1) Measurement of average particle size of raw material crystal nucleating agent (laser diffraction type particle size distribution measurement)
It measured by the following method using the laser-diffraction-type particle size distribution meter (The Malvern Instruments company make, "Mastersizer 3000"). First, by using a wet measurement cell, by thoroughly stirring and mixing, the sample is dispersed in an aqueous solution containing a nonionic surfactant as a dispersant, and subsequently, the obtained mixture is further stirred in the apparatus, While circulating, ultrasonic waves were applied to disperse the particles sufficiently uniformly in the apparatus. Then, the particle size distribution of the sample was measured while applying ultrasonic waves. From the obtained particle size distribution, a volume-based cumulative 50% particle size (d50) was determined and defined as an average particle size.
(2)本発明の顆粒状ポリオレフィン系樹脂用結晶核剤の粒径の測定(ふるい分け試験)
JIS K0069(1992)の6.1に準拠した条件で、ふるい分け試験を行い、目開き600μmのJIS試験用ふるい上の残存物の重量を化学天秤を用いて正確に測定した。得られた目開き600μmのふるい上の重量より、試験に用いた試料の全重量に対する割合を求めた。
(2) Measurement of particle size of crystal nucleating agent for granular polyolefin resin of the present invention (sieving test)
A sieving test was carried out under the conditions according to JIS K0069 (1992) 6.1, and the weight of the residue on the JIS test sieve having an opening of 600 μm was accurately measured using an analytical balance. The ratio of the sample used in the test to the total weight was determined from the weight of the obtained sieve having a mesh size of 600 μm.
(3)圧縮比の測定
漏斗をメスシリンダーの開口部上2cmとなるように、かつそれと軸が一致するように垂直に保持し、漏斗を通して100cm3のメスシリンダーに結晶核剤を100cm3ゆっくりと入れた。秤を用いてメスシリンダー内の結晶核剤の重量を0.1gの桁まで測定した。得られた重量より下記式(1)を用いてゆるめ嵩密度を求めた。続いて、メスシリンダーをゴムシートの上5cmの高さから垂直に落下させる操作(タッピング)を50回繰り返した。メスシリンダー内の結晶核剤の容量を0.1cm3の桁まで読み取り、下記式(2)を用いてかため嵩密度を求めた。得られたゆるめ嵩密度及びかため嵩密度より下記式(3)を用いて、圧縮比を求めた。一般的に、圧縮比が1に近いほど流動性に優れると言われている。
式(1);
ゆるめ嵩密度(g/cm3)=メスシリンダー内の結晶核剤の重量(g)/100cm3
式(2);
かため嵩密度(g/cm3)=メスシリンダー内の結晶核剤の重量(g)/タッピング後の結晶核剤の容量(cm3)
式(3);
圧縮比=かため嵩密度/ゆるめ嵩密度
(3) Measurement of compression ratio The funnel was held vertically at 2 cm above the opening of the graduated cylinder and with its axis aligned, and 100 cm 3 of the crystal nucleating agent was slowly passed through the funnel into the graduated cylinder of 100 cm 3. I put it in. The weight of the crystal nucleating agent in the measuring cylinder was measured to the order of 0.1 g using a balance. The loosened bulk density was determined from the obtained weight using the following formula (1). Subsequently, an operation (tapping) of dropping the measuring cylinder vertically from a height of 5 cm on the rubber sheet was repeated 50 times. The volume of the crystal nucleating agent in the graduated cylinder was read up to the digit of 0.1 cm 3 , and the bulk density was determined using the following formula (2). The compression ratio was determined from the obtained loose bulk density and firm bulk density using the following formula (3). It is generally said that the closer the compression ratio is to 1, the better the fluidity.
Formula (1);
Loose bulk density (g / cm 3 ) = weight of crystal nucleating agent in graduated cylinder (g) / 100 cm 3
Formula (2);
Firm bulk density (g / cm 3 ) = weight of crystal nucleating agent in graduated cylinder (g) / volume of crystal nucleating agent after tapping (cm 3 ).
Formula (3);
Compression ratio = firm bulk density / loose bulk density
[流動性の評価]
(4)安息角の測定
25℃、湿度60%の条件下で、結晶核剤30gを、漏斗上縁までの距離が1cmの高さから、開口部の直径9cm、穴の直径1cmの漏斗上へ注ぎ込み、振動させずに漏斗下口から10cmの位置にある直径9cmの円形台上に落下させる。落下した円錐状の堆積物の高さを測定し、水平面と母線のなす角を計算から求め、安息角(単位:度)とした。この安息角が小さいほど粉体流動性が良いことを示す。
[Evaluation of liquidity]
(4) Measurement of the angle of repose Under the conditions of 25 ° C. and humidity of 60%, 30 g of the crystal nucleating agent was placed on a funnel having a diameter of an opening of 9 cm and a hole of 1 cm from a height of 1 cm from the upper edge of the funnel. It is poured into a circular table having a diameter of 9 cm at a position 10 cm from the bottom of the funnel without shaking. The height of the falling cone-shaped deposit was measured, and the angle formed by the horizontal plane and the generatrix was calculated and used as the angle of repose (unit: degree). The smaller the angle of repose, the better the powder fluidity.
(5)粉体流動性試験(漏斗試験)
結晶核剤を、漏斗の上縁までの距離が5cmの高さから、開口部の直径15cm、穴の直径1.5cmの漏斗上へ注ぎ込み、振動させずに漏斗下口より落下させる。結晶核剤の漏斗から排出状態より、以下の基準に従って、結晶核剤の流動性を4段階評価にて判定した。
(評価基準)
◎:結晶核剤が全て速やかに漏斗から排出され、漏斗内壁の付着物もほとんど確認されない。
○:結晶核剤がわずかに漏斗から排出されずに残るが、わずかな衝撃により残った結晶核剤も全て排出される。
△:結晶核剤が漏斗から排出されずに残り、わずかな衝撃だけでは漏斗上に残った結晶核剤を完全に排出することは困難である。
×:結晶核剤が漏斗から排出されずに多量に残り、衝撃を与えても漏斗上に残った結晶核剤を排出することは困難である。
(5) Powder fluidity test (funnel test)
The crystal nucleating agent is poured from a height of 5 cm to the upper edge of the funnel onto a funnel having an opening diameter of 15 cm and a hole diameter of 1.5 cm, and dropped from the funnel lower opening without vibrating. From the discharge state of the crystal nucleating agent from the funnel, the fluidity of the crystal nucleating agent was evaluated by a 4-step evaluation according to the following criteria.
(Evaluation criteria)
⊚: All the crystal nucleating agent was quickly discharged from the funnel, and almost no deposits were confirmed on the inner wall of the funnel.
◯: The crystal nucleating agent slightly remains without being discharged from the funnel, but the crystal nucleating agent remaining due to a slight impact is also completely discharged.
Δ: The crystal nucleating agent remains without being discharged from the funnel, and it is difficult to completely discharge the crystal nucleating agent remaining on the funnel with a slight impact.
X: A large amount of the crystal nucleating agent remains without being discharged from the funnel, and it is difficult to discharge the crystal nucleating agent remaining on the funnel even when an impact is applied.
[ケーキング性の評価]
(6)ケーキング試験
顆粒状結晶核剤10gをビーカーに入れ、50℃に設定したオーブン中で、24時間静置し、取り出したビーカー内の顆粒状結晶核剤の性状を目視にて確認し、以下の4段階で分類評価した。
◎:塊ができない。
○:ほとんど塊ができないか、塊ができても非常に脆く、柔らかい。
△:塊ができるが、崩れやすく、実用上ほとんど問題にはならない。
×:全体的に塊になり、使用するためには解砕が必要である。
[Evaluation of caking property]
(6) Caking test 10 g of the granular crystal nucleating agent was placed in a beaker, allowed to stand in an oven set at 50 ° C. for 24 hours, and the properties of the granular crystal nucleating agent in the taken out beaker were visually confirmed. The following four grades were used for classification and evaluation.
A: No lump is formed.
○: Almost no lumps are formed, or even if lumps are formed, it is very brittle and soft.
Δ: A lump is formed, but it easily collapses, which poses practically no problem.
X: It becomes a lump as a whole, and it needs to be crushed before it can be used.
[成形体の性状]
(7)ヘイズ値の測定
東洋精機製作所製のヘイズメータを用いて、JIS K7136(2000)に準じた方法でヘイズ値を測定した。評価試料には、1mm厚み射出成形品のポリプロピレン系樹脂成形体を使用した。得られたヘイズ値の数値が小さい程、透明性に優れていることを示す。
[Properties of molded product]
(7) Measurement of haze value Using a haze meter manufactured by Toyo Seiki Seisakusho, the haze value was measured by a method according to JIS K7136 (2000). As the evaluation sample, a polypropylene-based resin molded body of 1 mm thick injection molded product was used. The smaller the obtained haze value, the better the transparency.
(8)白点評価
射出成形した50mm×50mm×1mm形状のポリオレフィン系樹脂成形体を評価試料として使用し、目視観察で成形体中の白点の数をカウントした。得られた結果は、試料5枚の平均値をとり、その試料の白点数とし、得られた評価結果より、以下の3段階で分類評価した。
◎:白点数が3個未満である。成形体の性能上、全く問題のないレベルである。
○:白点数が3〜15個の範囲である。核剤としての性能上、問題はないが、他の物性面で未分散物の影響が出る可能性がある。
×:白点数が15個を超えて存在が確認される。明らかに、核剤の性能面でも十分に効果が発現されておらず、更に未分散物が様々な物性面で問題を生ずる可能性が高い。
(8) White spot evaluation An injection-molded polyolefin resin molded body of 50 mm x 50 mm x 1 mm shape was used as an evaluation sample, and the number of white spots in the molded body was counted by visual observation. The obtained results were obtained by taking the average value of 5 samples and using them as the number of white points of the sample, and from the obtained evaluation results, classification and evaluation were performed according to the following 3 grades.
A: The number of white points is less than 3. There is no problem in terms of the performance of the molded product.
◯: The number of white points is in the range of 3 to 15. There is no problem in terms of performance as a nucleating agent, but the undispersed substance may affect other physical properties.
X: Existence is confirmed when the number of white points exceeds 15. Apparently, the effect of the nucleating agent has not been sufficiently exhibited, and the undispersed substance is likely to cause problems in various physical properties.
実施例中の化合物の略号
DMDBS:1,3:2,4−ビス−O−(3’,4’−ジメチルベンジリデン)−D−ソルビトール
PDBN:1,3:2,4−ビス−O−(p−n−プロピルベンジリデン)−1−n−プロピルソルビトール
GMS:ステアリン酸モノグリセリド
Irg1010:テトラキス[メチレン−3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]メタン(BASFジャパン(株)製、商品名「IRGANOX1010」)
CaSt:ステアリン酸カルシウム
Abbreviations for compounds in Examples DMDBS: 1,3: 2,4-bis-O- (3 ', 4'-dimethylbenzylidene) -D-sorbitol PDBN: 1,3: 2,4-bis-O- ( p-n-propylbenzylidene) -1-n-propylsorbitol GMS: stearic acid monoglyceride Irg1010: tetrakis [methylene-3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate] methane (BASF Japan ( Co., Ltd., trade name "IRGANOX1010")
CaSt: calcium stearate
[実施例1]
温度計を設置した20Lスーパーミキサー(株式会社カワタ製)に室温でDMDBS(新日本理化(株)製、ゲルオールDXR、平均粒径6.2μm)を1.5kg、GMS(理研ビタミン(株)製、融点:65℃)を0.5kg、Irg1010(融点;120℃)を0.3kg投入し、ジャケットを蒸気加熱しながら撹拌速度300rpmで撹拌した。粉体温度が65℃まで昇温した後、蒸気を停止し撹拌速度1500rpmで5分間撹拌し、本発明の顆粒状結晶核剤を得た。最終的な粉体温度は96℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して30重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、圧縮比、安息角を測定し、結果を表1に示した。同様に、得られた顆粒状結晶核剤を用いて、ケーキング性の評価及び粉体流動性試験(漏斗試験)による粉体流動性の評価を行い、結果を合わせて表1に示した。
[Example 1]
1.5 kg of DMDBS (manufactured by Shin Nippon Rika Co., Ltd., Gelol DXR, average particle size 6.2 μm), GMS (manufactured by Riken Vitamin Co., Ltd.) at room temperature in a 20 L super mixer (manufactured by Kawata Co., Ltd.) equipped with a thermometer. , Melting point: 65 ° C.) and Irg1010 (melting point; 120 ° C.) 0.3 kg were added, and the mixture was stirred at a stirring speed of 300 rpm while heating the jacket with steam. After the powder temperature was raised to 65 ° C., the steam was stopped and the mixture was stirred at a stirring speed of 1500 rpm for 5 minutes to obtain a granular crystal nucleating agent of the present invention. The final powder temperature was 96 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of the residue on the sieve having an opening of 600 μm of 30% by weight based on the total weight.
Then, the compression ratio and angle of repose were measured using the obtained granular crystal nucleating agent, and the results are shown in Table 1. Similarly, the obtained granular crystal nucleating agent was used to evaluate caking properties and powder fluidity by a powder fluidity test (funnel test), and the results are shown in Table 1.
[実施例2]
DMDBSの量を1.4kg、GMSの量を0.3kg、Irg1010の量を0.3kgに変えた以外は、実施例1と同様に実施して、顆粒状結晶核剤を得た。最終的な粉体温度は94℃であった。得られた顆粒状結晶核剤は、得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して58重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 2]
A granular crystal nucleating agent was obtained in the same manner as in Example 1 except that the amount of DMDBS was changed to 1.4 kg, the amount of GMS was changed to 0.3 kg, and the amount of Irg1010 was changed to 0.3 kg. The final powder temperature was 94 ° C. According to the result of the sieving test, the obtained granular crystal nucleating agent was found to have 58% by weight of the residue on the sieve having an opening of 600 μm based on the total weight. confirmed.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例3]
DMDBSの量を1.4kg、GMSの量を0.4kg、Irg1010の量を0.2kgに変えた以外は、実施例1と同様に実施して、顆粒状結晶核剤を得た。最終的な粉体温度は99℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して99重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 3]
A granular crystal nucleating agent was obtained in the same manner as in Example 1 except that the amount of DMDBS was changed to 1.4 kg, the amount of GMS was changed to 0.4 kg, and the amount of Irg1010 was changed to 0.2 kg. The final powder temperature was 99 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of the residue on the sieve having an opening of 600 μm of 99% by weight based on the total weight.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例4]
温度計を設置した20Lスーパーミキサーに室温でDMDBSを1.4kg、GMSを0.3kg、Irg1010を0.3kg投入し、ジャケットを蒸気加熱しながら撹拌速度300rpmで撹拌した。粉体温度が65℃になるまで昇温した後、蒸気を停止し撹拌速度1500rpmで5分間撹拌し、コアとなる顆粒状結晶核剤を得た。この時の粉体温度は96℃であった。続いて、攪拌を停止して、スーパーミキサー内にDMDBS0.1kgを追加投入し、再度撹拌速度1500rpmで3分間撹拌した。最終的な粉体温度は90℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して98重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 4]
To a 20 L super mixer equipped with a thermometer, 1.4 kg of DMDBS, 0.3 kg of GMS and 0.3 kg of Irg1010 were charged at room temperature, and the jacket was stirred at a stirring speed of 300 rpm while heating with steam. After raising the powder temperature to 65 ° C., the steam was stopped, and the mixture was stirred at a stirring speed of 1500 rpm for 5 minutes to obtain a granular crystal nucleating agent to be the core. The powder temperature at this time was 96 ° C. Then, the stirring was stopped, 0.1 kg of DMDBS was additionally charged into the super mixer, and the mixture was stirred again at a stirring speed of 1500 rpm for 3 minutes. The final powder temperature was 90 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of residue of 98% by weight based on the total weight on the sieve having an opening of 600 μm.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例5]
追加投入したDMDBSの量を0.2kgに変えた以外は、実施例4と同様に実施して、顆粒状結晶核剤を得た。最終的な粉体温度は87℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して84重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 5]
A granular crystal nucleating agent was obtained in the same manner as in Example 4 except that the amount of DMDBS additionally charged was changed to 0.2 kg. The final powder temperature was 87 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of the residue on the sieve having openings of 600 μm of 84% by weight based on the total weight.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例6]
DMDBSをPDBN(平均粒径;5.9μm)に変えた以外は、実施例2と同様に実施して、顆粒状結晶核剤を得た。最終的な粉体温度は95℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して50重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 6]
A granular crystal nucleating agent was obtained in the same manner as in Example 2, except that DMDBS was changed to PDBN (average particle size; 5.9 μm). The final powder temperature was 95 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of the residue on the sieve having an opening of 600 μm of 50% by weight based on the total weight.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例7]
Irg1010をCaSt(日東化成工業(株)社製、融点;148℃)に変えた以外は、実施例2と同様に実施して、顆粒状結晶核剤を得た。最終的な粉体温度は100℃であった。得られた顆粒状結晶核剤は、ふるい分け試験の結果より、目開き600μmのふるい上の残存物の割合が全重量に対して99重量%であることを確認した。
続いて、得られた顆粒状結晶核剤を用いて、実施例1と同様に圧縮比、安息角を測定し、更にケーキング性及び粉体流動性の評価を行い、その結果をまとめて表1に示した。
[Example 7]
A granular crystal nucleating agent was obtained in the same manner as in Example 2 except that Irg1010 was changed to CaSt (manufactured by Nitto Kasei Kogyo KK, melting point: 148 ° C). The final powder temperature was 100 ° C. From the results of the sieving test, it was confirmed that the obtained granular crystal nucleating agent had a ratio of the residue on the sieve having an opening of 600 μm of 99% by weight based on the total weight.
Then, using the obtained granular crystal nucleating agent, the compression ratio and the angle of repose were measured in the same manner as in Example 1, and the caking property and the powder fluidity were evaluated, and the results are summarized in Table 1. It was shown to.
[実施例8]
ポリオレフィン系樹脂としてポリプロピレンランダムコポリマー(MFR=7g/10分(荷重2160g、温度230℃)、(株)プライムポリマー社製、R−720)100重量部、結晶核剤として実施例1で得られた顆粒状結晶核剤0.31重量部、及びその他添加剤としてステアリン酸カルシウム(CaSt)0.05重量部、テトラキス[メチレン−3−(3,5−ジ−t−ブチル−4−ヒドロキシフェニル)プロピオネート]メタン(Irg1010)0.01重量部、テトラキス(2,4−ジ−t−ブチルフェニル)ホスファイト(BASFジャパン(株)製、商品名「IRGAFOS168」)0.05重量部をドライブレンドした。そのドライブレンド物を一軸押出機(田辺プラスチックス機械株式会社製VS―20)を用いてバレル温度250℃にて溶融混合後、押し出されたストランドを冷却し、ペレタイザーでカッティングして、ポリオレフィン系樹脂組成物を調製した。
[Example 8]
Polypropylene random copolymer as a polyolefin resin (MFR = 7 g / 10 min (load 2160 g, temperature 230 ° C.), R-720 manufactured by Prime Polymer Co., Ltd.) 100 parts by weight, obtained in Example 1 as a crystal nucleating agent 0.31 part by weight of a granular crystal nucleating agent, 0.05 part by weight of calcium stearate (CaSt) as another additive, tetrakis [methylene-3- (3,5-di-t-butyl-4-hydroxyphenyl) propionate ] 0.01 parts by weight of methane (Irg1010) and 0.05 parts by weight of tetrakis (2,4-di-t-butylphenyl) phosphite (manufactured by BASF Japan Ltd., trade name "IRGAFOS168") were dry blended. The dry blend was melt-mixed at a barrel temperature of 250 ° C. using a single-screw extruder (VS-20 manufactured by Tanabe Plastics Machinery Co., Ltd.), and the extruded strand was cooled and cut with a pelletizer to obtain a polyolefin resin. A composition was prepared.
続いて、得られたポリオレフィン系樹脂組成物を用いて、射出成形機(日精樹脂工業株式会社製NS40−5A)にて射出成形温度(加熱温度)240℃、金型温度(冷却温度)40℃の条件下で成形して、厚みが1mmおよび厚さ2mmのポリオレフィン系樹脂成形体を得た。 Subsequently, using the obtained polyolefin-based resin composition, an injection molding machine (NS40-5A manufactured by Nissei Plastic Industry Co., Ltd.) injection molding temperature (heating temperature) 240 ° C., mold temperature (cooling temperature) 40 ° C. By molding under the conditions of 1), a polyolefin resin molded product having a thickness of 1 mm and a thickness of 2 mm was obtained.
上記で得られた成形体を評価試料として用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。 The haze value was measured using the molded body obtained above as an evaluation sample, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例9]
結晶核剤として、実施例2で得られた顆粒状結晶核剤0.29重量部を用いた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 9]
A polyolefin-based resin composition and a polyolefin-based resin molded product were obtained in the same manner as in Example 8, except that 0.29 parts by weight of the granular crystal nucleating agent obtained in Example 2 was used as the crystal nucleating agent. Obtained. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例10]
結晶核剤として、実施例3で得られた顆粒状結晶核剤0.29重量部を用い、Irg1010の量を0.02重量部に変えた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 10]
As a crystal nucleating agent, 0.29 parts by weight of the granular crystal nucleating agent obtained in Example 3 was used, and the same procedure as in Example 8 was carried out except that the amount of Irg1010 was changed to 0.02 parts by weight, A polyolefin resin composition and a polyolefin resin molded product were obtained. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例11]
結晶核剤として、実施例4で得られた顆粒状結晶核剤0.28重量部を用いた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 11]
A polyolefin-based resin composition and a polyolefin-based resin molded product were obtained in the same manner as in Example 8, except that 0.28 part by weight of the granular crystal nucleating agent obtained in Example 4 was used as the crystal nucleating agent. Obtained. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例12]
結晶核剤として、実施例5で得られた顆粒状結晶核剤0.28重量部を用いた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 12]
A polyolefin-based resin composition and a polyolefin-based resin molded product were obtained in the same manner as in Example 8, except that 0.28 part by weight of the granular crystal nucleating agent obtained in Example 5 was used as the crystal nucleating agent. Obtained. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例13]
結晶核剤として、実施例6で得られた顆粒状結晶核剤0.29重量部を用いた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 13]
A polyolefin-based resin composition and a polyolefin-based resin molded product were obtained in the same manner as in Example 8, except that 0.29 parts by weight of the granular crystal nucleating agent obtained in Example 6 was used as the crystal nucleating agent. Obtained. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
[実施例14]
結晶核剤として、実施例7で得られた顆粒状結晶核剤0.29重量部を用い、Irg1010の量を0.05重量部に、ステアリン酸カルシウムの量を0.01重量部に変えた以外は、実施例8と同様に実施して、ポリオレフィン系樹脂組成物及びポリオレフィン系樹脂成形体を得た。得られた成形体を用いて、ヘイズ値を測定し、得られた結果を表2に示した。続いて、上記方法にて目視により成形体中の白点評価を行い、その結果を合わせて表2に示した。
[Example 14]
As the crystal nucleating agent, 0.29 part by weight of the granular crystal nucleating agent obtained in Example 7 was used, except that the amount of Irg1010 was changed to 0.05 part by weight and the amount of calcium stearate was changed to 0.01 part by weight. Was carried out in the same manner as in Example 8 to obtain a polyolefin resin composition and a polyolefin resin molded product. The haze value was measured using the obtained molded body, and the obtained results are shown in Table 2. Subsequently, the white spots in the molded body were visually evaluated by the above method, and the results are also shown in Table 2.
上記表1及び表2の結果より、本発明に係る顆粒状結晶核剤が、流動性に非常に優れており、更にケーキング等の問題もなく生産性に向上に大きく寄与するものであり、且つその顆粒状結晶核剤を含んでなるポリオレフィン系樹脂成形体が白点等の問題もなく、非常に優れた透明性を有するものであり、様々な用途で非常の有用であることがわかる。 From the results of Table 1 and Table 2 above, the granular crystal nucleating agent according to the present invention has very excellent fluidity and further contributes to the improvement in productivity without problems such as caking, and It can be seen that the polyolefin-based resin molded product containing the granular crystal nucleating agent does not have a problem such as white spots and has excellent transparency, and is very useful for various applications.
本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、流動性が大きく改良されており、非常に流動性に優れた結晶核剤として、様々な用途で使用することができる。また、本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、ポリオレフィン系樹脂中での分散性や溶解性についても従来の結晶核剤と同等かそれ以上の性能を有し、成形品の性能的にも非常に有用である。従って、本発明の顆粒状ポリオレフィン系樹脂用結晶核剤は、様々な用途で生産性の向上などに大きく寄与することが可能であり、得られたポリオレフィン系樹脂成形体は、結晶核剤の未分散物や未溶解物による白点等の欠点がなく、かつ透明性等の光学的特性や耐衝撃性等の機械的特性に優れており、自動車部材、電気部材、機械部品、日用雑貨、衣装等のケース、食品等の容器など、様々な用途で広く使うことができる。 The crystal nucleating agent for a granular polyolefin resin of the present invention has greatly improved fluidity and can be used in various applications as a crystal nucleating agent having excellent fluidity. Further, the crystal nucleating agent for granular polyolefin-based resin of the present invention has the same or higher performance as the conventional crystal nucleating agent with respect to dispersibility and solubility in the polyolefin-based resin. Is also very useful. Therefore, the crystal nucleating agent for granular polyolefin-based resin of the present invention can greatly contribute to the improvement of productivity in various applications, and the obtained polyolefin-based resin molded product has no crystal nucleating agent. It has no defects such as white spots due to dispersions and undissolved substances, and has excellent optical properties such as transparency and mechanical properties such as impact resistance, and is used for automobile parts, electrical parts, mechanical parts, daily necessities, It can be widely used for various purposes such as clothes cases and food containers.
Claims (8)
前記コア部分の顆粒状ポリオレフィン系樹脂用結晶核剤組成物は、(A)下記一般式(1)で示されるジアセタール系化合物からなるポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド、(C)100℃以上の融点を有するヒンダードフェノール系化合物を含んでなり、
前記コア部分の顆粒状ポリオレフィン系樹脂用結晶核剤組成物中に占める(A)成分の割合が60〜80重量%であり、(B)成分の割合が10〜30重量%であり、(B)成分と(C)成分の合計の割合が20〜40重量%であり、更に、
前記コア部分の顆粒状ポリオレフィン系樹脂用結晶核剤組成物は、(B)成分と(C)成分の合計量中に占める(B)成分の割合が30〜80重量%であり、且つ、粉体温度を(B)成分の融点以上、(C)成分の融点以下の温度範囲に制御しながら、加熱攪拌造粒されたものであり、更に、
JIS K0069(1992)に準拠した条件で行ったふるい分け試験において、目開き600μmのJIS試験用ふるい上の残存物の全重量に対する割合が10重量%以上であることを特徴とする顆粒状ポリオレフィン系樹脂用結晶核剤組成物。
The crystal nucleating agent composition for a granular polyolefin resin in the core portion comprises (A) a crystal nucleating agent for a polyolefin resin composed of a diacetal compound represented by the following general formula (1) , (B) an organic acid monoglyceride, ( C) comprising a hindered phenolic compound having a melting point above 100 ° C.,
The proportion of the component (A) in the crystal nucleus agent composition for a granular polyolefin resin of the core portion is 60 to 80% by weight, the proportion of the component (B) is 10 to 30% by weight, and ) Component and (C) component in a total proportion of 20 to 40% by weight, and
In the crystal nucleating agent composition for a granular polyolefin resin of the core portion, the proportion of the component (B) in the total amount of the component (B) and the component (C) is 30 to 80% by weight, and the powder the body temperature of component (B) above the melting point, while controlling the following temperatures the melting point of component (C) state, and are not heated stirring granulation, further,
In screening tests conducted under the conditions conforming to JIS K0069 (1992), granular polyolefin which relative to the total weight of the residue on sieve for JIS test mesh opening 600μm is characterized der Rukoto 10 wt% or more A crystal nucleating agent composition for resins.
(i)(A)下記一般式(1)で示されるジアセタール系化合物からなるポリオレフィン系樹脂用結晶核剤、(B)有機酸モノグリセリド、及び(C)100℃以上の融点を有するヒンダードフェノール系化合物を、粉体温度を(B)成分の融点以上、(C)成分の融点以下の温度範囲に制御しながら、攪拌造粒して、顆粒状ポリオレフィン系樹脂用結晶核剤組成物を得る工程、
(ii)工程(i)で得られた顆粒状ポリオレフィン系樹脂用結晶核剤組成物に、更に(D)下記一般式(1)で示されるジアセタール系化合物からなるポリオレフィン系樹脂用結晶核剤を加えて、粉体温度を(B)成分の融点以上、工程(i)の粉体温度未満の温度範囲に制御しながら、加熱混合して、顆粒状ポリオレフィン系樹脂用結晶核剤組成物を得る工程を具備し、前記顆粒状ポリオレフィン系樹脂用結晶核剤組成物がJIS K0069(1992)に準拠した条件で行ったふるい分け試験において、目開き600μmのJIS試験用ふるい上の残存物の全重量に対する割合が10重量%以上であることを特徴とする製造方法。
(I) (A) A crystal nucleating agent for a polyolefin resin, which comprises a diacetal compound represented by the following general formula (1) , (B) an organic acid monoglyceride, and (C) a hindered phenol system having a melting point of 100 ° C. or higher. The step of stirring and granulating the compound while controlling the powder temperature in the temperature range from the melting point of the component (B) to the melting point of the component (C) to obtain a granular nucleating agent composition for polyolefin resin. ,
(Ii) In addition to the granular nucleating agent composition for polyolefin resin obtained in step (i), (D) a crystalline nucleating agent for polyolefin resin comprising a diacetal compound represented by the following general formula (1). In addition, while controlling the powder temperature in the temperature range not lower than the melting point of the component (B) and lower than the powder temperature in the step (i), heating and mixing are performed to obtain a crystal nucleating agent composition for granular polyolefin resin. In the sieving test conducted by the crystal nucleating agent composition for granular polyolefin resin under the conditions according to JIS K0069 (1992), the total weight of the residue on the JIS test sieve having an opening of 600 μm A manufacturing method characterized in that the proportion is 10% by weight or more .
上記で得られた顆粒状のポリオレフィン系樹脂用結晶核剤組成物と更に添加された(D)下記一般式(1)で示されるジアセタール系化合物からなるポリオレフィン系樹脂用結晶核剤とを、粉体温度を(B)成分の融点以上、前記の撹拌混合時の粉体温度未満の温度範囲に制御しながら、加熱混合することによりJIS K0069(1992)に準拠した条件で行ったふるい分け試験において、目開き600μmのJIS試験用ふるい上の残存物の全重量に対する割合が10重量%以上である顆粒状とする、ポリオレフィン系樹脂用結晶核剤組成物の流動性改良方法。
The granular crystal nucleating agent composition for polyolefin resin obtained above and (D) a crystal nucleating agent for polyolefin resin composed of a diacetal compound represented by the following general formula (1) In a sieving test carried out under the conditions according to JIS K0069 (1992) by heating and mixing while controlling the body temperature to a temperature range not lower than the melting point of the component (B) and lower than the powder temperature at the time of stirring and mixing , A method for improving the fluidity of a crystal nucleating agent composition for a polyolefin-based resin, which comprises a granule having a ratio of 10% by weight or more to the total weight of the residue on a JIS test sieve having an opening of 600 μm .
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016181073A JP6679450B2 (en) | 2016-09-16 | 2016-09-16 | Crystal nucleating agent for granular polyolefin resin with improved fluidity |
PCT/JP2017/033009 WO2018052010A1 (en) | 2016-09-16 | 2017-09-13 | Crystal nucleator for polyolefin resins, method for producing crystal nucleator for polyolefin resins, and method for improving fluidity of crystal nucleator for polyolefin resins |
US16/333,387 US11746211B2 (en) | 2016-09-16 | 2017-09-13 | Crystal nucleator for polyolefin resins, method for producing crystal nucleator for polyolefin resins, and method for improving fluidity of crystal nucleator for polyolefin resins |
CN201780055021.5A CN109689765A (en) | 2016-09-16 | 2017-09-13 | The modification method of the mobility of polyolefin-based resins crystallization nucleating agent, the manufacturing method of polyolefin-based resins crystallization nucleating agent and polyolefin-based resins crystallization nucleating agent |
EP17850911.3A EP3514201A4 (en) | 2016-09-16 | 2017-09-13 | Crystal nucleator for polyolefin resins, method for producing crystal nucleator for polyolefin resins, and method for improving fluidity of crystal nucleator for polyolefin resins |
CN202210414934.4A CN114685852A (en) | 2016-09-16 | 2017-09-13 | Crystal nucleating agent for polyolefin resin, method for producing same, method for improving fluidity, polyolefin resin composition, and molded article |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016181073A JP6679450B2 (en) | 2016-09-16 | 2016-09-16 | Crystal nucleating agent for granular polyolefin resin with improved fluidity |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018044093A JP2018044093A (en) | 2018-03-22 |
JP6679450B2 true JP6679450B2 (en) | 2020-04-15 |
Family
ID=61694576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016181073A Active JP6679450B2 (en) | 2016-09-16 | 2016-09-16 | Crystal nucleating agent for granular polyolefin resin with improved fluidity |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6679450B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7194851B2 (en) * | 2018-06-27 | 2022-12-22 | 旭化成株式会社 | Polyacetal powder, method of use thereof, and additive manufacturing method |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0732454A (en) * | 1993-07-16 | 1995-02-03 | Kanegafuchi Chem Ind Co Ltd | Blow molding resin composition and blow molding method |
JP2003096246A (en) * | 2001-09-27 | 2003-04-03 | New Japan Chem Co Ltd | Manufacturing method of additive composition for granular polyolefin resin |
EP2246388A1 (en) * | 2009-04-27 | 2010-11-03 | Sumitomo Chemical Company, Limited | Granular stabilizer formulation and production method thereof |
JP5992364B2 (en) * | 2013-05-31 | 2016-09-14 | 株式会社Adeka | Method for producing clarifying agent composition and method for producing polyolefin resin composition containing the same |
-
2016
- 2016-09-16 JP JP2016181073A patent/JP6679450B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2018044093A (en) | 2018-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI626264B (en) | Transparent agent composition and polyolefin-based resin composition containing the same | |
US8486303B2 (en) | Granule mass | |
JP5920524B2 (en) | Diacetal-containing composition, polyolefin resin composition, and resin molded body | |
KR100842164B1 (en) | Diacetal Composition, Nucleating Agent Containing the Composition for Polyolefin, Polyolefin Resin Composition Containing the Diacetal Composition, Process for Producing the Resin Composition, and Molded Object | |
JP6394376B2 (en) | Diacetal-containing composition | |
US6417254B1 (en) | Particulate diacetal composition, process for producing the same, and polyolefin resin composition and molding | |
US20230219972A1 (en) | Crystal nucleating agent for polyolefin resin, method for producing crystal nucleating agent for polyolefin resin, and method for improving fluidity of crystal nucleating agent for polyolefin resin | |
US11746211B2 (en) | Crystal nucleator for polyolefin resins, method for producing crystal nucleator for polyolefin resins, and method for improving fluidity of crystal nucleator for polyolefin resins | |
JP5050486B2 (en) | Granules and method for producing the same | |
JP5109462B2 (en) | Method for producing polyolefin composition | |
US10894874B2 (en) | Crystal nucleator for polyolefin resins, method for producing crystal nucleator for polyolefin resins, and method for improving fluidity of crystal nucleator for polyolefin resins | |
JP6679450B2 (en) | Crystal nucleating agent for granular polyolefin resin with improved fluidity | |
JP6694142B2 (en) | Method for improving fluidity of crystal nucleating agent for polyolefin resin | |
JP6694139B2 (en) | Crystal nucleating agent for polyolefin resin | |
JP6849912B2 (en) | Method for improving fluidity of crystal nucleating agent for polyolefin resin | |
JP2017218471A (en) | Polyolefin resin master batch and method for producing the same, and polyolefin resin molded body using the master batch | |
JP6849913B2 (en) | Crystal nucleating agent for fine particle polyolefin resin with improved fluidity | |
JP6867593B2 (en) | Granular polyolefin resin crystal nucleating agent with improved fluidity | |
JP6912708B2 (en) | Crystal nucleating composition for polyolefin resins with improved fluidity | |
JP2020029573A (en) | Method of improving transparent feeling of polyolefin resin compact, transparent nucleus agent composition, polyolefin resin composition, production method of polyolefin resin composition and polyolefin resin compact | |
CN109661424B (en) | Crystal nucleating agent for polyolefin resin, method for producing crystal nucleating agent for polyolefin resin, and method for improving fluidity of crystal nucleating agent for polyolefin resin | |
JP2019011277A5 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160920 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170822 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170823 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20170925 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20170925 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190327 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191224 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200220 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200317 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200318 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6679450 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |